👤 Ye Wang

🔍 Search 📋 Browse 🏷️ Tags ❤️ Favourites ➕ Add 🧪 BiometalDB 🧬 Extraction
4397
Articles
2763
Name variants
Also published as: Junli Wang, Xindi Wang, Junpeng Wang, Tingyu Wang, Guoqiang Wang, Yuxuan Wang, Hanzhi Wang, Zhi-Long Wang, Shanshan Wang, Wenfei Wang, Dengbin Wang, Yen-Sheng Wang, Chuanxin Wang, Zeyu Wang, Beibei Wang, Taicheng Wang, Xingguo Wang, Z P Wang, Yue-Min Wang, Chenghua Wang, Xianqiang Wang, Congrong Wang, Yanhai Wang, Du Wang, Xianzhe Wang, Zuoheng Wang, Yongyi Wang, Zhihui Wang, Yanhua Wang, Limeng Wang, H J Wang, Pei-Jian Wang, Yana Wang, Congrui Wang, Larry Wang, Yu-Zhuo Wang, Sihua Wang, Wanchun Wang, Jialin Wang, Xinying Wang, Shuguang Wang, Yinhuai Wang, Xiaobin Wang, Yuying Wang, Hebo Wang, Leli Wang, Jiayu Wang, Zhaojun Wang, Hai Wang, Si Wang, Re-Hua Wang, Xuping Wang, Bo Wang, Shubao Wang, Songjiao Wang, Hongjia Wang, Victoria Wang, Ling Wang, Jianjie Wang, Haining Wang, Dali Wang, Ji-Yang Wang, Cheng Wang, Weifan Wang, Yuanqiang Wang, Zhixiao Wang, Yaxian Wang, Zhigang Wang, Haochen Wang, Jia-Ying Wang, Shichao Wang, Ruosu Wang, N Wang, Haixing Wang, Guiqun Wang, Zhiting Wang, Dan Wang, Wangxia Wang, Jing-Long Wang, Yaqian Wang, Yafang Wang, Xing-Jun Wang, Dapeng Wang, Zhongyuan Wang, Junsheng Wang, Zhaohai Wang, He-Ping Wang, Minmin Wang, Wenzhou Wang, Zhaohui Wang, Yanfang Wang, Pengtao Wang, Leran Wang, Qianwen Wang, Hongkun Wang, Sa Wang, Y Alan Wang, Liyan Wang, Jou-Kou Wang, Mingda Wang, Chenfei Wang, Yuehan Wang, Simeng Wang, Yuhua Wang, Ruibin Wang, Haibo Wang, Ni Wang, Guoxiu Wang, Zhuangzhuang Wang, Yajie Wang, Zhixiang Wang, Sangui Wang, Xiantao Wang, Yan-Yang Wang, Mengjun Wang, Ruling Wang, Peihe Wang, Miao Wang, Zaihua Wang, Jun-Jie Wang, Mengyao Wang, Zhiyu Wang, Changzhen Wang, Xijun Wang, Chengjian Wang, Yiyi Wang, Mo Wang, Xiaolun Wang, Danan Wang, Fanchang Wang, Zilin Wang, Fanhua Wang, Supeng Perry Wang, Gavin Wang, Yi-Ying Wang, Yani Wang, Zhuowei Wang, Weiwei Wang, Haifeng Wang, Yi-Shiuan Wang, Yan-Chao Wang, Xiaotong Wang, Jia-Qi Wang, Yongliang Wang, Yongming Wang, Fengchong Wang, Jianyong Wang, Zeping Wang, Huaquan Wang, Xiaojia Wang, Tao Wang, Tianjun Wang, Siying Wang, Zhenze Wang, Zhijian Wang, Li Wang, Heming Wang, Jingtong Wang, Xuefei Wang, Yingqiao Wang, Xiao Qun Wang, Chun-Chieh Wang, Shuang-Xi Wang, Laiyuan Wang, Zhaoming Wang, Yinggui Wang, Qi-Jia Wang, Wen-Yan Wang, Mingming Wang, Peipei Wang, Chien-Hsun Wang, Qiuhong Wang, Monica Wang, Lexin Wang, Xiufen Wang, Yuehua Wang, Pingfeng Wang, Caiyan Wang, Weijie Wang, Yigang Wang, Jieyan Wang, Huiquan Wang, Chunsheng Wang, Yunhe Wang, Changtu Wang, Qingliang Wang, Guanghua Wang, Yongbin Wang, Zhaobo Wang, Minghui Wang, Junshi Wang, Jingyu Wang, Longsheng Wang, Fen Wang, Xianshu Wang, Jianwu Wang, Jun-Zhuo Wang, Zhixing Wang, Lei Wang, Yiyan Wang, Jinglin Wang, Jinhe Wang, Enhua Wang, Yuecong Wang, Xueying Wang, Jennifer T Wang, Xin-Hua Wang, Shijie Wang, Chun-Xia Wang, Yuanjiang Wang, Xiaojun Wang, Shunjun Wang, Chun-Juan Wang, M Wang, Jinfei Wang, Jinghuan Wang, Xuru Wang, Xiao-Lan Wang, Yu-Chen Wang, Zhi-Guo Wang, Luya Wang, Shuwei Wang, Pingchuan Wang, Qifan Wang, Xing-Quan Wang, Weiding Wang, Xuebin Wang, Yaling Wang, Chenyin Wang, Allen Wang, Liyuan Wang, Rong-Rong Wang, Wusan Wang, Wayseen Wang, Qianru Wang, Yi-Xin Wang, Hailin Wang, Yu-Hang Wang, Xuesong Wang, Haojie Wang, Wanxia Wang, Mengwen Wang, Hanping Wang, Yuhang Wang, Lueli Wang, Xinchang Wang, Oliver Wang, Shuge Wang, Jianhao Wang, Chong Wang, Kui Wang, Litao Wang, Zining Wang, Ming-Yang Wang, Hongxia Wang, Mingyi Wang, Hai Bo Wang, Bingnan Wang, Hongqian Wang, Jisheng Wang, Jiakun Wang, Maoju Wang, Xiaoqiu Wang, Dongyi Wang, Hai Yang Wang, Pengju Wang, Xiaofeng Wang, Huming Wang, Jian'an Wang, Qianrong Wang, Xiaowei Wang, Xiangkun Wang, Da Wang, Hongying Wang, Changying Wang, Changyu Wang, Xiaoqin Wang, Zhenxi Wang, Qiaoqiao Wang, Yu Tian Wang, Yupeng Wang, Xinli Wang, YueJiao Wang, Jian-chun Wang, Pengchao Wang, Xiao-Juan Wang, Siqing Wang, C Z Wang, Pengbo Wang, Baoli Wang, Yu-Zhe Wang, Gui-Qi Wang, Dazhi Wang, Yanwen Wang, Xingqin Wang, Shijin Wang, Wenming Wang, Fanxiong Wang, Tiansong Wang, Shuzhe Wang, Jie Wang, Jinling Wang, Yunfang Wang, Luyao Wang, Cun-Yu Wang, Zikang Wang, Quan-Ming Wang, Yingying Wang, Chia-Chuan Wang, Xintong Wang, Jufeng Wang, Xuejun Wang, Xiao-Qian Wang, Yijin Wang, Meng Yu Wang, Tianyi Wang, Chia-Lin Wang, Zhuo-Jue Wang, Yaohe Wang, Rong Wang, Hao-Hua Wang, Yong-Jun Wang, Xubo Wang, Dalong Wang, Yan-Ge Wang, Erika Y Wang, Ruixian Wang, Jin-Liang Wang, Shicung Wang, Saifei Wang, Jintao Wang, Zhenzhen Wang, Jiawei Wang, Beilei Wang, Huabo Wang, Huiyu Wang, Hongtao Wang, Chengjun Wang, Guo-Du Wang, Taoxia Wang, Zitao Wang, Jingwen Wang, Yibin Wang, Long Wang, Xinjing Wang, Qunzhi Wang, Liangliang Wang, Bangchen Wang, Yu-Fen Wang, Shibin Wang, Congcong Wang, Xiong Wang, Zhiren Wang, Xiaozhu Wang, Hong-Xia Wang, Qingyong Wang, Tianying Wang, Tammy C Wang, Huijie Wang, Tiansheng Wang, Mengzhao Wang, Jianshu Wang, Xinlong Wang, Benzhong Wang, Zhipeng Wang, Kaijie Wang, Xiaomin Wang, Peijun Wang, Zhiqiang Wang, Jundong Wang, Zheng Wang, Yueze Wang, Sujuan Wang, Qing-Yun Wang, Xiaoqing Wang, Zongqi Wang, Zhicun Wang, Fudi Wang, Seok Mui Wang, Wanbing Wang, Kejun Wang, Nanping Wang, Mingyang Wang, Wenxia Wang, Yaru Wang, Zikun Wang, Shidong Wang, Bei Bei Wang, Yu-Hui Wang, Rui Wang, Yige Wang, Tongxin Wang, Xiaohua Wang, Changjing Wang, Xingjin Wang, Bingjie Wang, Shaoyu Wang, Hui-Hui Wang, Zhenyu Wang, Baoying Wang, Yang-Yang Wang, Shi-Yao Wang, Lifei Wang, Fangfang Wang, Zhimei Wang, Kunpeng Wang, Binglong Wang, Daijun Wang, Qinghang Wang, Zi Wang, Shushu Wang, QingDong Wang, Qing K Wang, Fuhua Wang, Yanni Wang, Jianle Wang, Wenyan Wang, Jinning Wang, Ziqi Wang, Wei-Qi Wang, Yaolou Wang, Haoming Wang, Jian-Wei Wang, Tian Wang, Peixi Wang, Iris X Wang, Tongxia Wang, Mei-Xia Wang, Haiying Wang, Tielin Wang, Hongze Wang, Chung-Hsi Wang, Peiyao Wang, Linli Wang, Guanru Wang, Yuzhong Wang, Yunhan Wang, Jianan Wang, Menglong Wang, Yingxue Wang, Jiayi Wang, Dingxiang Wang, Ting Wang, Fenglin Wang, Jianqun Wang, Ran Wang, Kuan Hong Wang, Liusong Wang, Wen-Der Wang, Yixuan Wang, Feng Wang, Kaicen Wang, Eryao Wang, Yulei Wang, Huaibing Wang, Zhongzhi Wang, Jinrong Wang, Sujie Wang, Xiaozhong Wang, Xiao-Pei Wang, Li-Na Wang, H X Wang, Linjie Wang, Zhaosong Wang, Yafen Wang, Chuan-Wen Wang, Xiaoning Wang, Li-Xin Wang, Silas L Wang, Baocheng Wang, Hongyi Wang, Zhi-Xiao Wang, Shengjie Wang, Zhi-Hao Wang, Yaokun Wang, Shao-Kang Wang, Qunxian Wang, Jianghui Wang, Zhao Wang, Di Wang, Jianzhi Wang, Ruijing Wang, Ling Jie Wang, Qingshi Wang, Jianye Wang, Yuqiang Wang, Kangling Wang, Anxin Wang, Shengli Wang, Zhulin Wang, Hua-Wei Wang, Yiwen Wang, Yang Wang, Hanqi Wang, Changwei Wang, Honglei Wang, Yi Lei Wang, Wenkang Wang, Junjie Wang, Yazhou Wang, Peng-Cheng Wang, Chenzi Wang, Anqi Wang, Yuemiao Wang, Xuelin Wang, Rujie Wang, Dongyan Wang, Yuxue Wang, Wengong Wang, Qigui Wang, Junqing Wang, Ruhan Wang, Xinye Wang, Huihui Wang, Gengsheng Wang, Mark Wang, Zhidong Wang, Mengmeng Wang, Yuwen Wang, Liang Wang, Huaxiang Wang, Fangjun Wang, Huixia Wang, Haijiao Wang, Hong-Hui Wang, Yi-Shan Wang, Yunchao Wang, Junjun Wang, Binghai Wang, Xinguo Wang, Jun-Sing Wang, Lingzhi Wang, Yuexiang Wang, Hong-Gang Wang, Yen-Feng Wang, Xidi Wang, Jiawen Wang, Liangfu Wang, Lifeng Wang, Shihan Wang, Wentian Wang, Sa A Wang, Lee-Kai Wang, Yu-Wei Wang, Zumin Wang, Shau-Chun Wang, Jianjiao Wang, Tian-Tian Wang, Jiantao Wang, Edward Wang, Jianbo Wang, Qingfeng Wang, Wenran Wang, Xiaolin Wang, Fenghua Wang, Rongjia Wang, Shiqiang Wang, Caixia Wang, Guihu Wang, Xindong Wang, Wenxiu Wang, Xueguo Wang, YiLi Wang, Aizhong Wang, Qiqi Wang, Chengcheng Wang, D Wang, L Wang, Jianhua Wang, Qiuling Wang, Shaolian Wang, Wen-Qing Wang, Wenqing Wang, Yuchuan Wang, Guangdi Wang, Yiquan Wang, Huimei Wang, Genghao Wang, Zun Wang, Miranda C Wang, Annette Wang, Chi-Ping Wang, Hanmin Wang, Zhaoxi Wang, Shifeng Wang, Runze Wang, Mangju Wang, Junjiang Wang, Dong D Wang, Xiu-Ping Wang, Haijiu Wang, Linghuan Wang, Yiying Wang, Renqian Wang, Nana Wang, Xiangdong Wang, Shiyin Wang, Chaoyi Wang, Menghan Wang, Shuyue Wang, Yongmei Wang, Nanbu Wang, Lihua Wang, Hongyue Wang, Jianli Wang, Chunli Wang, Minghua Wang, Junkai Wang, Chenguang Wang, Siyue Wang, Jun Wang, Shu-Song Wang, Bingyan Wang, Qingping Wang, Zhong-Yu Wang, Fei-Fei Wang, Jennifer E Wang, Z-Y Wang, Dongxia Wang, Dang Wang, Zi-Hao Wang, Rihua Wang, Jutao Wang, Yanzhe Wang, Guohao Wang, Liming Wang, Yishu Wang, Xuemin Wang, Xianfeng Wang, Zixu Wang, Jingfan Wang, Guang-Jie Wang, Guixue Wang, Jiaojiao Wang, Yaxin Wang, Haibing Wang, Weizhong Wang, Hairong Wang, Hai-Jun Wang, Mingji Wang, Yongrui Wang, Huizhi Wang, Longfei Wang, Chongmin Wang, Jingyang Wang, Zhong-Ping Wang, Huanhuan Wang, Baisong Wang, Xiaohui Wang, Fengyang Wang, Wanliang Wang, Ziqiang Wang, Chuan Wang, Jeffrey Wang, Ying-Zi Wang, Ziwei Wang, Xian Wang, Hanyu Wang, Qiming Wang, Dedong Wang, Fengying Wang, Xiaoya Wang, Zhenhua Wang, Yanchun Wang, Keming Wang, Zi-Yi Wang, Dezhong Wang, Jingying Wang, Shouli Wang, Lan-lan Wang, Weiyu Wang, Yuhuai Wang, Jun Yi Wang, Wenying Wang, Xue-Feng Wang, Xing-Lei Wang, Yuehong Wang, Pengyu Wang, Yihe Wang, Guodong Wang, Weijian Wang, Wu-Wei Wang, Y Wang, Ruonan Wang, Jianbing Wang, Mian Wang, Dennis Qing Wang, Nannan Wang, Zuo Wang, Christine Wang, Ruixin Wang, Yaxiong Wang, Siwei Wang, Yuanzhen Wang, Wen-Chang Wang, Haijing Wang, X Wang, Melissa T Wang, Haixia Wang, Qianghu Wang, Hongsheng Wang, Xiurong Wang, Shaowei Wang, Shuo Wang, Zengtao Wang, Yun-Xing Wang, Songtao Wang, Mei Wang, Mengyun Wang, Qingming Wang, Ke-Feng Wang, Zhihao Wang, Haoqi Wang, X E Wang, Xin-Shang Wang, Dongmei Wang, Lingli Wang, Huai-Zhou Wang, Hua Wang, Kunzheng Wang, Mao-Xin Wang, Jingzhou Wang, Jiaqi Wang, Xingbang Wang, Wence Wang, Yongdi Wang, Xin-Qun Wang, Guoyi Wang, Jian-Guo Wang, Jiafu Wang, Pin Wang, Libo Wang, Junling Wang, J Z Wang, Haozhou Wang, Jing Wang, Hezhi Wang, T Q Wang, Xi-Hong Wang, Yuanfan Wang, Endi Wang, Hua-Qin Wang, Jeremy Wang, Songping Wang, Suyun Wang, Jiqing Wang, Shu-Ling Wang, Jennifer X Wang, Lily Wang, Yin-Hu Wang, Jen-Chywan Wang, Qingqing Wang, Shuangyuan Wang, Haihong Wang, Luyun Wang, Yake Wang, Ya-Nan Wang, Weicheng Wang, Jianxiang Wang, Zihua Wang, Lin Wang, Fu-Sheng Wang, Zongbao Wang, Tong-Hong Wang, Xianze Wang, Ting-Ting Wang, Haibin Wang, Xin-Yue Wang, Zhi-Gang Wang, Ziying Wang, Shukang Wang, Wen-Jun Wang, Delin Wang, Yating Wang, Xuehao Wang, Yefu Wang, Yi-Ning Wang, Cheng-zhang Wang, Jing J Wang, Xinglong Wang, Yanqing Wang, Tongyao Wang, Dongyang Wang, Deqi Wang, Qiao Wang, Alice Wang, Yunzhi Wang, Dayong Wang, Renxi Wang, Yeh-Han Wang, Mingya Wang, Longxiang Wang, Hualin Wang, Hailei Wang, Ao Wang, Wanyu Wang, Jiale Wang, Qiangcheng Wang, Huishan Wang, Yunqiong Wang, Xudong Wang, Xifu Wang, Wen-Xuan Wang, Dao Wen Wang, Zhi-Wei Wang, Xingchen Wang, Yanyang Wang, Yutao Wang, Huizhen Wang, Hu WANG, Y P Wang, Wen Wang, Qingsong Wang, Baofeng Wang, Ruo-Ran Wang, Yaobin Wang, Changliang Wang, Pintian Wang, Dai Wang, Su-Guo Wang, Ruting Wang, Fengzhen Wang, Qinrong Wang, HuiYue Wang, Baosen Wang, Shuhe Wang, Yifei Wang, Jiun-Ling Wang, Junhui Wang, Guangzhi Wang, Qijia Wang, Yushe Wang, Jinlong Wang, Zhouguang Wang, Huiyao Wang, Shuxin Wang, Yingyi Wang, Jing-Yi Wang, Yongxiang Wang, Zhi Wang, Dehao Wang, Yi-sheng Wang, Jiazhi Wang, Yunfei Wang, Mingjin Wang, Yaozhi Wang, Jinyu Wang, Jinmeng Wang, LiLi Wang, Shuai Wang, Yan Wang, Jun Kit Wang, Cui Wang, Zhan Wang, Dong-Jie Wang, Yangyang Wang, Xiangguo Wang, Runuo Wang, Ruimin Wang, Pengpu Wang, Nuan Wang, Guangyan Wang, Xin-Liang Wang, Minxiu Wang, Ruifang Wang, Hui Wang, Hongda Wang, Xiyan Wang, Jinxia Wang, Xinchen Wang, Haihua Wang, Delong Wang, Yayu Wang, Xue-Hua Wang, Xin-Peng Wang, Changqian Wang, Bei Wang, Ya-Han Wang, Chih-Liang Wang, P N Wang, Xiaoqian Wang, Xianshi Wang, Zhiruo Wang, Xueding Wang, Renxiao Wang, Yi-Ming Wang, Tianqi Wang, Ledan Wang, Rongyun Wang, Gan Wang, Qinqin Wang, Yuxiang Wang, Feimiao Wang, Mengyuan Wang, Chaofan Wang, Linshuang Wang, Yanhui Wang, Zhenglong Wang, Zongkui Wang, Zhenwei Wang, Xiyue Wang, Yi Fan Wang, Xiao-Ai Wang, Po-Jen Wang, Xinyang Wang, Linying Wang, Fa-Kai Wang, Yimeng Wang, Dong-Mei Wang, Anli Wang, Hui-Li Wang, Jianqing Wang, Honglun Wang, Wei-Feng Wang, Kaihao Wang, Jialing Wang, Shuren Wang, Cui-Fang Wang, Wenqi Wang, Peilin Wang, Wen-Fei Wang, Guang-Rui Wang, T Wang, Weiqing Wang, Ciyang Wang, Biao Wang, Kaihe Wang, Jieh-Neng Wang, Tony Wang, Yuehu Wang, Zhicheng Wang, Tongtong Wang, Zi Xuan Wang, Yingtai Wang, Xin-Xin Wang, Chu Wang, Tianhao Wang, Shukui Wang, Ching C Wang, Yulin Wang, Chunyang Wang, Yeqi Wang, Yinbo Wang, Kongyan Wang, Weiling Wang, Linxuan Wang, Shengya Wang, Yaqi Wang, Huating Wang, Aiting Wang, Ya Xing Wang, Daoping Wang, Shasha Wang, Wei-Lien Wang, Quanli Wang, Yanru Wang, L M Wang, Bijue Wang, H Wang, Jipeng Wang, Xiaoxia Wang, Shuu-Jiun Wang, Baitao Wang, Haimeng Wang, Chung-Hsing Wang, Weining Wang, M Y Wang, Wenwen Wang, Zhongsu Wang, Xiaochen Wang, Ligang Wang, Shaohsu Wang, Bing Qing Wang, Jiangbin Wang, Yajun Wang, Chunting Wang, Hemei Wang, En-hua Wang, H-Y Wang, Zixi Wang, Wenjing Wang, Haikun Wang, Ruxin Wang, Jianru Wang, Yongqiang Wang, Ouchen Wang, Jianyu Wang, Shen Wang, Yixi Wang, Zhi-Hong Wang, Li Dong Wang, Zhou-Ping Wang, Wen-Yong Wang, Meng-Lan Wang, Xiaojie Wang, Leying Wang, Yi-Zhen Wang, Y Y Wang, Jianlin Wang, Guoqing Wang, Jiani Wang, Guan-song Wang, You Wang, Xiangding Wang, Ke Wang, Wendong Wang, Yue Wang, Zhe Wang, K Wang, Zhuo Wang, Su'e Wang, Cangyu Wang, Erfei Wang, Xiaoming Wang, Aijun Wang, Xiaoye Wang, Jun-Sheng Wang, Wenxiang Wang, Yanjun Wang, Qiangqiang Wang, Yachun Wang, Haitao Wang, Tiancheng Wang, Gangyang Wang, Jianmin Wang, Jiabo Wang, Yijing Wang, Mengzhi Wang, Yinuo Wang, Zhou Wang, Guiying Wang, Xuezheng Wang, Shan Wang, Aoli Wang, Fuqiang Wang, Yawei Wang, Xianxing Wang, Ya-Long Wang, Yuyang Wang, Dong Hao Wang, Y-S Wang, Zelin Wang, Liqun Wang, Cunyi Wang, Qian-Zhu Wang, Yinan Wang, Panfeng Wang, Guangwen Wang, J Q Wang, Guang Wang, Yu-Ping Wang, John Wang, Jiaping Wang, Zhisheng Wang, Xuan-Ren Wang, Xiaowu Wang, Zhengyu Wang, Baowei Wang, Zhijun Wang, Zhong-Hao Wang, Fengzhong Wang, Jin-Da Wang, Zhaoqing Wang, Yuanbo Wang, Haixin Wang, Yaping Wang, Lixiu Wang, Mingxia Wang, Neng Wang, Guozheng Wang, Yan-Feng Wang, Huafei Wang, Yuhan Wang, Xingxing Wang, Wenhe Wang, Xing-Huan Wang, Xiansong Wang, Yishan Wang, Ruming Wang, Ya Qi Wang, Yueying Wang, Chunle Wang, Shihua Wang, W Wang, Hengjun Wang, Meihui Wang, Huanyu Wang, Ruinan Wang, Qiwei Wang, Zhong Wang, Shiyao Wang, Jian-Zhi Wang, Ruimeng Wang, Jinxiang Wang, Jinsong Wang, Bin-Xue Wang, Fuwen Wang, Yiou Wang, Shifa Wang, Yin Wang, Yanzhu Wang, Jia Bin Wang, Siyang Wang, Zhanggui Wang, Yueting Wang, Qingyu Wang, Qianqian Wang, Xiu-Lian Wang, Fengling Wang, Chenxi Wang, Cheng An Wang, Yipeng Wang, Weipeng Wang, Zechen Wang, Shuaiqin Wang, Xueqian Wang, Chan Wang, Guohang Wang, Cai-Yun Wang, Jiang Wang, Huei Wang, Yufeng Wang, Heng Wang, Qing-Liang Wang, Chuang Wang, Xiaofang Wang, Hao-Ching Wang, Junying Wang, Jianwei Wang, Jinhai Wang, Hanchao Wang, Penglai Wang, I-Ching Wang, S L Wang, Tianhu Wang, Sheng-Min Wang, Pan-Pan Wang, Duan Wang, Xuqiao Wang, Minghuan Wang, Wei-Wei Wang, Xiaojian Wang, Shuping Wang, Jinfu Wang, Biqi Wang, Zhenguo Wang, Fangyan Wang, Sainan Wang, Peijuan Wang, Pei-Yu Wang, Yuyan Wang, Fuxin Wang, Ji M Wang, Yange Wang, Yali Wang, Wenhui Wang, Leishen Wang, Lichan Wang, Xianna Wang, Wenbin Wang, Kenan Wang, Chih-Yuan Wang, Yanlei Wang, Ju Wang, Yanliang Wang, Keqing Wang, Bangshing Wang, Dayan Wang, Yongsheng Wang, Dinghui Wang, Zheyue Wang, Xinke Wang, Daqing Wang, Yan Ming Wang, He-Ling Wang, Shengyao Wang, Jiwen Wang, Xizhi Wang, Luxiang Wang, Dandan Wang, RongRong Wang, Heng-Cai Wang, Jindan Wang, Xiaoding Wang, Yumeng Wang, Heling Wang, Xiao-Yun Wang, Meiding Wang, Zhilun Wang, Guo-hong Wang, Na Wang, Yanli Wang, Fubing Wang, Feixiang Wang, Zhiyuan Wang, Yi-Cheng Wang, Zhengwei Wang, Wenyuan Wang, Yu-Ying Wang, Jianqin Wang, Sijia Wang, Chuansen Wang, Huawei Wang, Kaiyan Wang, Qingyuan Wang, Yujia Wang, Lian Wang, Junrui Wang, Chao-Yung Wang, Zehao Wang, Ruixue Wang, Minjun Wang, Jin Wang, Xiaoxiao Wang, Jun-Feng Wang, Binquan Wang, Shuxia Wang, Donggen Wang, Deming Wang, Chenggang Wang, Chuduan Wang, Haichuan Wang, Catherine Ruiyi Wang, Hai-Feng Wang, Anthony Z Wang, Guanghui Wang, Jiahao Wang, Xiaosong Wang, Zijue Wang, Wenbo Wang, M-J Wang, Yu Wang, Yingping Wang, Zhengbing Wang, G Q Wang, Mengjing Wang, Zhendong Wang, Kailu Wang, Jinfeng Wang, Zhiguo Wang, Yusha Wang, Jianmei Wang, Kun Wang, Lihong Wang, Haoxin Wang, Haowei Wang, Ziqing Wang, Aihua Wang, Yuanyong Wang, Sanwang Wang, Doudou Wang, Hao-Yu Wang, Peirong Wang, Wenting Wang, Yibing Wang, He Wang, Jia-Peng Wang, Shixin Wang, En-bo Wang, Dong-Dong Wang, Hualing Wang, Hongyan Wang, Shaoying Wang, Yingjie Wang, Tianqing Wang, Guo-Hua Wang, Yongfei Wang, Lijing Wang, Hongli Wang, Zixian Wang, Niansong Wang, Liangxu Wang, Xinrong Wang, X-T Wang, Zhenning Wang, Dake Wang, Yu-Ting Wang, Zonggui Wang, Daping Wang, Joy Wang, Chenji Wang, Jingmin Wang, Yuyin Wang, Jin-Cheng Wang, Jiangbo Wang, Huiyang Wang, Chi Chiu Wang, He-Cheng Wang, Zhongjing Wang, Weina Wang, Qiaohong Wang, Qintao Wang, Jenny Y Wang, Zheyi Wang, Robert Yl Wang, Zhaotong Wang, Ya Wang, Fangyu Wang, Haobin Wang, Tianyuan Wang, Xinrui Wang, Zhehao Wang, Yihan Wang, Chuan-Jiang Wang, Jianjun Wang, Yongfeng Wang, Gaofu Wang, Ying-Piao Wang, Jingwei Wang, Mengjiao Wang, Chuyao Wang, Yanping Wang, Xinchun Wang, Shu Wang, Guibin Wang, Hong-Ying Wang, Linping Wang, Yugang Wang, Xinru Wang, Fengyun Wang, Heyong Wang, Ziping Wang, Yuegang Wang, Xiangyu Wang, Haoran Wang, Xiaomei Wang, Fang Wang, Lina Wang, Guowen Wang, Liyun Wang, Qingshui Wang, Baoyun Wang, Li-Juan Wang, Tongsong Wang, Jingyun Wang, Huiguo Wang, Zhibo Wang, Lou-Pin Wang, Renjun Wang, Huiting Wang, Junfeng Wang, Zihan Wang, Linhua Wang, Zhiji Wang, Fubao Wang, Eunice S Wang, Xiaojuan Wang, Yuewei Wang, Shuang Wang, Ruey-Yun Wang, Xiaoling Wang, Weihua Wang, Yanggan Wang, Jia Wang, Chaoqun Wang, Xiao-liang Wang, Manli Wang, Yongkang Wang, Huiwen Wang, Ting Chen Wang, Yixian Wang, Xinlin Wang, Shuya Wang, Bochu Wang, Kehao Wang, Sasa Wang, Mengshi Wang, Qiu-Ling Wang, Chengshuo Wang, Mengru Wang, Yiwei Wang, Xueyun Wang, Yijun Wang, Haomin Wang, Meng C Wang, Mengxiao Wang, Huan-You Wang, Jingheng Wang, Carol A Wang, Benjamin H Wang, Penglong Wang, Pei-Wen Wang, Jian-Long Wang, Wang Wang, Jinhui Wang, Yuanqing Wang, Jacob E Wang, Jian-Xiong Wang, Wenyu Wang, Chengze Wang, Hongmei Wang, Fengqiang Wang, Zijun Wang, Shaochun Wang, Qinwen Wang, Ruicheng Wang, Aixian Wang, Yanling Wang, Lu-Lu Wang, Linyuan Wang, Yeming Wang, Tian-Yi Wang, Zhichao Wang, Dangfeng Wang, Jiucun Wang, Guo-Liang Wang, Guandi Wang, Zhuo-Xin Wang, Aili Wang, Fengliang Wang, Yingzi Wang, Lirong Wang, Xuekai Wang, Wei-En Wang, Jing-Xian Wang, Hesuiyuan Wang, Yuexin Wang, Suzhen Wang, Luping Wang, Xiuyu Wang, Zicheng Wang, Jiliang Wang, Rikang Wang, Xue Wang, Shudan Wang, Chun Wang, Hongxin Wang, Chenglong Wang, Junxiao Wang, Zhiqing Wang, Shawn Wang, Shunran Wang, Tiantian Wang, Youhua Wang, Xiao-Hui Wang, Qing-Yan Wang, Hanying Wang, Qiuping Wang, Yongzhong Wang, Jin-Xia Wang, Xiao-Tong Wang, Shun Wang, Xiaoqun Wang, Ching-Jen Wang, Xin Wang, Hanbin Wang, Yingwen Wang, Jia Bei Wang, Xiaodan Wang, Wenhan Wang, Jia-Yu Wang, Xiaozhi Wang, Xinkun Wang, Jinhao Wang, KeShan Wang, Shengdong Wang, Jinzhu Wang, Lihui Wang, Bicheng Wang, Chao-Jun Wang, Shaoyi Wang, Yajing Wang, Qing-Bin Wang, Feiyan Wang, Geng Wang, Chen Wang, Zhimin Wang, Cenxuan Wang, Wenjun Wang, Chuan-Chao Wang, Zexin Wang, Shu-Huei Wang, Yonggang Wang, Zhaoyu Wang, Xiaochuan Wang, Chuan-Hui Wang, Junshuang Wang, X F Wang, Li-Ting Wang, Chenxin Wang, Qiao-Ping Wang, Jingqi Wang, Xiongjun Wang, Shuang-Shuang Wang, Xu Wang, Houchun Wang, Yaodong Wang, Lujuan Wang, Jilin Wang, Peichang Wang, Keyun Wang, Ruixuan Wang, Zhangying Wang, Lianyong Wang, Dongyu Wang, Xinghui Wang, Binghan Wang, Guanduo Wang, Xian-e Wang, Guimin Wang, Xiaomeng Wang, Yuh-Hwa Wang, Jinru Wang, Mingyu Wang, Binbin Wang, Chaokui Wang, Linhui Wang, Youzhi Wang, Zhenqian Wang, Jialiang Wang, Sufang Wang, Haiyan Wang, Yankun Wang, Yingbo Wang, Zilong Wang, Xiao-Qun Wang, Lin-Fa Wang, Wenhao Wang, P Wang, Rui-Hong Wang, Xiao-jian WANG, Pei Chang Wang, Zhengkun Wang, Vivian Wang, Ying Wang, Zihuan Wang, Peiwen Wang, Chao Wang, Da-Zhi Wang, He-Tong Wang, Mofei Wang, Zezhou Wang, Liyong Wang, Bruce Wang, Hao-Tian Wang, Jin-Juan Wang, Yucheng Wang, Yong-Gang Wang, Saili Wang, Xiuwen Wang, Ruiquan Wang, Xinmei Wang, Zhezhi Wang, Xiao-Jie Wang, H Y Wang, Li-Dong Wang, Duanyang Wang, Kaiting Wang, Yikang Wang, Yichen Wang, Ting-Chen Wang, Meixia Wang, ZhenXue Wang, Juan Wang, Shouling Wang, Lan Wang, Li Chun Wang, Xingxin Wang, Ruibing Wang, Xue-Ying Wang, Bi-Dar Wang, Jiayang Wang, Suxia Wang, Yumin Wang, Qing Jun Wang, Xinbo Wang, Youli Wang, Yi-Ni Wang, Xinran Wang, Lixian Wang, Kan Wang, Ruiming Wang, Qing-Yuan Wang, Kai-Kun Wang, Yaoxian Wang, Qing-Jin Wang, Junmei Wang, Xin Wei Wang, J P Wang, Xufei Wang, Yuqin Wang, Handong Wang, Li-San Wang, Guoling Wang, Wenrui Wang, Zhongwei Wang, Shi-Han Wang, Ruoxi Wang, Huiping Wang, Mu Wang, Weihong Wang, Minzhou Wang, Yakun Wang, Da-Cheng Wang, Pengjie Wang, Qihua Wang, Ji-Nuo Wang, Deshou Wang, Xiaowen Wang, Yaochun Wang, Qihao Wang, Ruiying Wang, Tiange Wang, Xi Wang, Yindan Wang, Lixin Wang, Zhaofeng Wang, Guixin Wang, Erming Wang, Haoyu Wang, Kexin Wang, Yiqiao Wang, Qi-Qi Wang, Shuiyun Wang, Xi-Rui Wang, Cai-Hong Wang, Zhizheng Wang, Mingxun Wang, Liangli Wang, Theodore Wang, Alexander Wang, Huayang Wang, Yinyin Wang, Shuzhong Wang, Tingting Wang, Jiao Wang, Wenxian Wang, Jianghua Wang, Furong Wang, Shijun Wang, Le Wang, Guihua Wang, Xiaokun Wang, Xia Wang, Jiabei Wang, Guoying Wang, Zeyuan Wang, Jue Wang, Jin-E Wang, Jingru Wang, Chun-Li Wang, Xiaole Wang, Ermao Wang, Lanlan Wang, Ye-Ran Wang, Hao Wang, Xv Wang, Shikang Wang, Yufei Wang, Siyi Wang, Xiujuan Wang, Qinyun Wang, Xiangwei Wang, Jian-Hong Wang, David Q-H Wang, Chunjuan Wang, Weiyan Wang, Jia-Liang Wang, Yanxing Wang, Sheri Wang, Chenwei Wang, Haoping Wang, Sheng-Quan Wang, Xiangrong Wang, Xiao-Yi Wang, Huan Wang, Zhitao Wang, Xinyan Wang, J Wang, Kaixi Wang, Huihua Wang, Renwei Wang, Xiaoliang Wang, Xiao-Lin Wang, Tian-Lu Wang, Jiou Wang, Weiqin Wang, Jiamin Wang, Dennis Wang, Ji-Yao Wang, Pingping Wang, Jinyang Wang, Chen-Cen Wang, Chien-Wei Wang, Daolong Wang, Rong-Tsorng Wang, Yuwei Wang, Guo-Ping Wang, Zhentang Wang, F Wang, Xueju Wang, Saisai Wang, Zhehai Wang, Y B Wang, Xiao Wang, Guobing Wang, Kangmei Wang, Chunguo Wang, Longcai Wang, Haina Wang, Chih-Hsien Wang, Yuli Wang, Ling-Ling Wang, Zhangshun Wang, Xue-Lian Wang, Jianxin Wang, Da-Yan Wang, Xianghua Wang, Peng Wang, Yu Qin Wang, Zhao-Jun Wang, Rui-Rui Wang, Xingyue Wang, Man Wang, Daozhong Wang, Tian-Li Wang, Luhui Wang, Gaopin Wang, Mengze Wang, Jizheng Wang, Hong-Yan Wang, Dongying Wang, Wenkai Wang, Stephani Wang, Dan-Dan Wang, Yicheng Wang, Yusheng Wang, Junwen Wang, Gao Wang, Ruo-Nan Wang, Yifan Wang, Jueqiong Wang, Xuewei Wang, Jianning Wang, Yonglun Wang, Shiwen Wang, Lifang Wang, Fuyan Wang, Jian-Bin Wang, Chonglong Wang, Haiwei Wang, Yike Wang, Chunxia Wang, Kaijuan Wang, Minglei Wang, Jingxiao Wang, Luting Wang, David Wang, Ben Wang, Ji-zheng Wang, Yuncong Wang, Lei P Wang, Tingye Wang, Wenke Wang, Ping Wang, Min Wang, Qiang-Sheng Wang, Xuejing Wang, Zhanju Wang, Xixi Wang, Xiaodong Wang, Chaomeng Wang, Yanong Wang, Xinghao Wang, Jiaming Wang, Siyuan Wang, Jiu Wang, Ruizhi Wang, Qing Mei Wang, Wenyi Wang, Yiqing Wang, Cai Ren Wang, Lianchun Wang, Xing-Ping Wang, Xiaoman Wang, Yanjin Wang, Xueqin Wang, Chenliang Wang, Zhenshan Wang, Junhong Wang, Guiping Wang, Xianrong Wang, Xumeng Wang, Dajia Wang, Huang Wang, Huie Wang, Weiwen Wang, Ruiwen Wang, Qing Wang, Haohao Wang, Bao-Long Wang, P Jeremy Wang, Chengqiang Wang, Suli Wang, Lingyan Wang, Chi Wang, Meng Wang, Luwen Wang, Quan Wang, Yan-Jun Wang, Sen Wang, Ruining Wang, Xiaozhen Wang, Zhiping Wang, Xue-Yao Wang, Yuming Wang, Jingjing Wang, Jiazheng Wang, Yunong Wang, Chongze Wang, Rufang Wang, Qiuning Wang, Tiannan Wang, Liqing Wang, Wencheng Wang, Xuefeng Wang, Yongli Wang, Xinwen Wang, Runzhi Wang, Chaojie Wang, Wentao Wang, Zhifeng Wang, Yanan Wang, Mengqi Wang, Limin Wang, Donglin Wang, Shujin Wang, Chengbin Wang, Qiu-Xia Wang, Zhengxuan Wang, Yancun Wang, Yuhuan Wang, Wei Wang, G-W Wang, Bangmao Wang, Kejia Wang, Jinjin Wang, Qifei Wang, Guobin Wang, Chun-Lin Wang, Jing-Shi Wang, Jiheng Wang, Huajing Wang, Yanlin Wang, Chuansheng Wang, Cailian Wang, Beilan Wang, Luofu Wang, Yangpeng Wang, Jieqi Wang, Weilin Wang, Xiaoxuan Wang, Yangyufan Wang, Xiao-Fei Wang, Chen-Ma Wang, Yun Yong Wang, Shizhi Wang, B Wang, Yuling Wang, Yi-Yi Wang, Fanwen Wang, Aiyun Wang, Jian Wang, Chengyu Wang, Jing-Huan Wang, Ning Wang, Yichuan Wang, L F Wang, Chau-Jong Wang, Xin-Yang Wang, Yunzhe Wang, Xuewen Wang, Sheng-Ping Wang, Bi Wang, Qiuting Wang, Yan-Jiang Wang, Dongshi Wang, Yingna Wang, Jingyue Wang, Hongshan Wang, Chunjiong Wang, Hong-Yang Wang, Yingmei Wang, Danfeng Wang, Zhongyi Wang, Teng Wang, Chih-Hao Wang, Mingchao Wang, Yi-Chuan Wang, Chuning Wang, Shihao Wang, Ming-Wei Wang, Menglu Wang, Zhulun Wang, Wuji Wang, Dao-Xin Wang, Han Wang, Jincheng Wang, Thomas T Y Wang, Qingyun Wang, Guoliang Wang, Jihong Wang, Hong-Qin Wang, G Wang, Hsei-Wei Wang, Linfang Wang, Xiao Ling Wang, Ganyu Wang, Zhengdong Wang, Cuizhe Wang, Hongyu Wang, Tieqiao Wang, Lijuan Wang, Jingchun Wang, Youzhao Wang, Zijian Wang, Ziheng Wang, Xingyu Wang, Shuning Wang, Shaokun Wang, Zhifu Wang, Xinqi Wang, Jinqiu Wang, ZhongXia Wang, Yanyun Wang, Dadong Wang, Xingjie Wang, Yiting Wang, Zhongli Wang, Junyu Wang, Jianding Wang, Meng-Wei Wang, Yingge Wang, Zhenchang Wang, Qun Wang, Jin-Xing Wang, Lijun Wang, Shuqing Wang, Fu-Yan Wang, Sheng-Nan Wang, Feijie Wang, Qiuyan Wang, Ying-Wei Wang, Shitao Wang, Meng-hong Wang, Zhengyang Wang, Jinghong Wang, Zhiying Wang, Pei Wang, Weixue Wang, Shiyue Wang, Xiaohong Wang, Daiwei Wang, Jinghua Wang, S X Wang, Jian-Yong Wang, Zeying Wang, Can Wang, Kehan Wang, Yunzhang Wang, Jinping Wang, Chenchen Wang, Chun-Ting Wang, Yujiao Wang, Xinxin Wang, Ji Wang, Sui Wang, Wenqiang Wang, Yingwei Wang, Shuzhen Wang, Daixi Wang, Yanming Wang, Lin-Yu Wang, Hongyin Wang, Zhongqun Wang, Er-Jin Wang, Yi Wang, Ziyi Wang, Lianghai Wang, Zhendan Wang, Xiao-Ming Wang, Chengyan Wang, Hui Miao Wang, Jingyi Wang, Ranran Wang, Banghui Wang, Huilun Wang, Ai-Ting Wang, Wenxuan Wang, Yuan-Hung Wang, Zixuan Wang, Hailing Wang, Xuan-Ying Wang, Jiqiu Wang, Yalong Wang, Xiaogang Wang, Shu-qiang Wang, Yun-Jin Wang, Zijie Wang, Tianlin Wang, Mingqiang Wang, Lufang Wang, Jin'e Wang, Xiru Wang, Cuili Wang, GuoYou Wang, Zhizhong Wang, Haifei Wang, Guorong Wang, Xinyue Wang, Pei-Juan Wang, Jiangong Wang, Yingte Wang, Huajin Wang, Ruibo Wang, Kejian Wang, Cheng-Cheng Wang, Xusheng Wang, Shu-Na Wang, Panliang Wang, Mingxi Wang, Shenqi Wang, Zifeng Wang, Chaozhan Wang, Xiuyuan Hugh Wang, Yuping Wang, Xujing Wang, Kai Wang, Hongbing Wang, Sheng-Yang Wang, Jianfei Wang, Hang Wang, Jing-Jing Wang, Weizhi Wang, Jixuan Wang, De-He Wang, P L Wang, Ningjian Wang, Chunyi Wang, Isabel Z Wang, Yong Wang, Yiming Wang, Mingzhi Wang, Jiying Wang, Qian-Wen Wang, Shusen Wang, Xiaoting Wang, Baogui Wang, Mingsong Wang, Zixia Wang, Demin Wang, Shiyuan Wang, Qiuli Wang, C Wang, Dongliang Wang, Weixiao Wang, Yinsheng Wang, Chunmei Wang, Huaili Wang, Xuelian Wang, Yongjun Wang, Zhi-Qin Wang, Jiaying Wang, Yulong Wang, Ren Wang, Jingnan Wang, Qishan Wang, Zeneng Wang, Guangsuo Wang, Chijia Wang, Huiqun Wang, Hongcai Wang, Donghao Wang, Xing-Jin Wang, Zongji Wang, Shenao Wang, Jiaqian Wang, Xiaoying Wang, Yilin Wang, Hangzhou Wang, Wenchao Wang, Jieyu Wang, Li-E Wang, Xuezhen Wang, Liuyang Wang, Zhiqian Wang, Fang-Tao Wang, Qiong Wang, Meng-Meng Wang, Youji Wang, Jiafeng Wang, Xiaojing Wang, William Wang, Junmin Wang, Laijian Wang, Xuexiang Wang, Huiyan Wang, T Y Wang, Zhaofu Wang, Wen-mei Wang, Yalin Wang, Xinshuai Wang, Daqi Wang, Zhen Wang, Shi-Cheng Wang, Anni Wang, Chunhong Wang, Hai-Long Wang, Pan Wang, Charles C N Wang, Pengxiang Wang, Xianzong Wang, Xike Wang, Qianliang Wang, Chunyan Wang, Xuan Wang, Xiaofen Wang, Zhi-Jian Wang, Feng-Sheng Wang, Xiangru Wang, R Wang, Yi-Shu Wang, Jia-Lin Wang, Yonghong Wang, Lintao Wang, Pai Wang, Yanfei Wang, Xuanwen Wang, Lei-Lei Wang, Chenxuan Wang, James Wang, Xinhui Wang, Shengqi Wang, Yueshen Wang, Shan-Shan Wang, Dingting Wang, Zhige Wang, Jingfeng Wang, Yongqing Wang, Chenyang Wang, Ziliang Wang, Bao Wang, Xueyan Wang, Liping Wang, Xingde Wang, Weijun Wang, Sibo Wang, Yaoling Wang, Donghong Wang, Chenyu Wang, Justin Wang, Baolong Wang, Yiqi Wang, Fengyong Wang, Lichao Wang, Yachen Wang, Quanren Wang, Shiyu Wang, Boyu Wang, Aimin Wang, Zhenghui Wang, Hengjiao Wang, Xiaoxin X Wang, Weimin Wang, Mutian Wang, Zhuo-Hui Wang, Xingye Wang, Zou Wang, Yu-Wen Wang, Shaoli Wang, Xin-Ming Wang, Weirong Wang, Kangli Wang, Yaoxing Wang, Xuejie Wang, Qifeng Wang, Xiaoxin Wang, Yinghui Wang, Jianzhang Wang, Tom J Wang, Yaqiong Wang, Zongwei Wang, Yun-Hui Wang, Haiyun Wang, Zhiyou Wang, Lijin Wang, Jifei Wang, Haiyong Wang, Xiao-Xia Wang, Shyi-Gang P Wang, Chih-Yang Wang, Zhixin Wang, Jun-Jun Wang, Tianjing Wang, Zhixia Wang, Chuanhai Wang, Zhijie Wang, Silu Wang, Jianguo Wang, Ming-Hsi Wang, Liling Wang, Yanting Wang, Haolong Wang, Xue-Lei Wang, Ru Wang, Qinglin Wang, Christina Wang, Mimi Wang, Menghui Wang, Wenju Wang, Junhua Wang, S S Wang, Fangyong Wang, Lifen Wang, Zhenbin Wang, Yapeng Wang, Shaoshen Wang, B R Wang, Sugai Wang, Hequn Wang, Songlin Wang, Wenjie Wang, Xiang-Dong Wang, Ting-Hua Wang, Mingliang Wang, Chengniu Wang, Guoxiang Wang, E Wang, Xiaochun Wang, Xueting Wang, Ming-Jie Wang, Zhaojing Wang, Dongxu Wang, Yirui Wang, Jiatao Wang, Jing-Min Wang, Shih-Wei Wang, Zhengchun Wang, Chaoxian Wang, Zehua Wang, Qiyu Wang, Shuye Wang, Baojun Wang, Qing Kenneth Wang, Xichun Wang, Jianliu Wang, Junping Wang, Yudong Wang, Mingzhu Wang, Kangning Wang, Wei-Ting Wang, Hongfang Wang, Chengwen Wang, Changduo Wang, Jinkang Wang, Junya Wang, Fengge Wang, Jianping Wang, Chang Wang, Zhifang Wang, Deli Wang, Linghua Wang, Shitian Wang, Lingling Wang, Zhihua Wang, Jun-Ling Wang, Keyi Wang, Lingbing Wang, Peijia Wang, Ruizhe Wang, X O Wang, Wanyi Wang, Ganggang Wang, Pei-Hua Wang, Kaiyue Wang, Xiaojiao Wang, Xun Wang, Shiyang Wang, Ya-Ping Wang, Yirong Wang, Lixing Wang, Danyang Wang, Xiaotang Wang, Taian Wang, Ming Wang, Xiangcheng Wang, Xuemei Wang, Zhixiong Wang, Mengying Wang, Li-Yong Wang, Xinchao Wang, Jianlong Wang, Jinjie Wang, Nan Wang, Weidong Wang, Mei-Gui Wang, L-S Wang, Wuqing Wang, Z Wang, Ya-Zhou Wang, Xincheng Wang, Jing-Wen Wang, Jinyue Wang, Hongyun Wang, Huaizhi Wang, Yan-Zi Wang, Danling Wang, Dongqin Wang, Hongzhuang Wang, Chung-Teng Wang, Yan-Chun Wang, Shi-Xin Wang, Muxuan Wang, Yujie Wang, Yunbing Wang, Yahui Wang, Zhihong Wang, Xiaoshan Wang, Tienju Wang, Chiou-Miin Wang, Yuqian Wang, Shengyuan Wang, Yumei Wang, Ningyuan Wang, Minjie Wang, Zhenda Wang, Qing-Dong Wang, Horng-Dar Wang, Siqi Wang, Kaihong Wang, Hong-Kai Wang, Meiling Wang, Jiaxing Wang, Xueyi Wang, Zhuozhong Wang, Anlai Wang, Julie Wang, Jin-Bao Wang, Keke Wang, Zhang Wang, Yintao Wang, Yong-Bo Wang, Bing Wang, Dalu Wang, Minxian Wang, Zulong Wang, Gao T Wang, Gang Wang, Sophie H Wang, Xinquan Wang, Yi-Ting Wang, Honglian Wang, Ruyue Wang, Jia-Qiang Wang, Seungwon Wang, Shusheng Wang, Yanbin Wang, Chang-Yun Wang, Le-Xin Wang, Juling Wang, Haohui Wang, Chuanyue Wang, Tianqin Wang, Danqing Wang, Keyan Wang, Yeou-Lih Wang, Qinglu Wang, Sun Wang, Rui-Min Wang, Yong-Tang Wang, Xianwei Wang, Lixia Wang, Tong Wang, Xiaonan Wang, Feida Wang, Jiaxuan Wang, Mingrui Wang, Zixiang Wang, Y Z Wang, Yuliang Wang, Ming-Chih Wang, J J Wang, Huina Wang, Jingang Wang, Jinyun Wang, Min-sheng Wang, Wanyao Wang, Ziqiu Wang, Guo-Quan Wang, Xueping Wang, Qixue Wang, Hechuan Wang, Shang Wang, Chaohan Wang, M H Wang, L Z Wang, Jianhui Wang, Xifeng Wang, Xiaorong Wang, Yinong Wang, Zhixiu Wang, Jiaxi Wang, Jiahui Wang, Xiaofei Wang, Feifei Wang, Kesheng Wang, Rong-Chun Wang, Zhi-Xin Wang, Chaoyu Wang, Yongkuan Wang, Zuoyan Wang, Hsueh-Chun Wang, Xixiang Wang, Guanrou Wang, Songsong Wang, Hongyuan Wang, Yubing Wang, Xuliang Wang, Wen-Ying Wang, Xinglei Wang, Dao-Wen Wang, Yun Wang, Ze Wang, Jiyan Wang, Zai Wang, Guan Wang, Chih-Chun Wang, Yiqin Wang, X S Wang, Hongzhan Wang, Exing Wang, Shu-Jin Wang, Shangyu Wang, Shouzhi Wang, Yunduan Wang, Jiyong Wang, Dongdong Wang, Qingzhong Wang, Zi-Qi Wang, Renyuan Wang, Siyu Wang, Donghui Wang, Ming-Yuan Wang, Juxiang Wang, Muxiao Wang, Fu Wang, Fei Wang, Qiuyu Wang, Ertao Wang, Zhi Xiao Wang, Zunxian Wang, Hui-Nan Wang, Rongping Wang, Won-Jing Wang, Leiming Wang, Pu Wang, Shen-Nien Wang, Xiaona Wang, Meng-Ying Wang, Wen-Jie Wang, Jiaxin Wang, RuNan Wang, Jiemei Wang, Ningli Wang, Zhong-Hui Wang, Hong Wang, Hui-Yu Wang, Ziqian Wang, Xinzhou Wang, Zhoufeng Wang, Weiguang Wang, Zusen Wang, Jiajia Wang, Bin Wang, Shu-Xia Wang, Yu'e Wang, Laidi Wang, Xiao-Li Wang, Lu Wang, Zhugang Wang, Maojie Wang, Ganglin Wang, Xinyu Wang, Junlin Wang, Dong Wang, Yao Wang, Ya-Jie Wang, Zhiwu Wang, DongWei Wang, Hongdan Wang, Yanxia Wang, Maiqiu Wang, Guansong Wang, Qingtong Wang, Yingcheng Wang, Wenjuan Wang, Liying Wang, Xiaolong Wang, Weihao Wang, Qiushi Wang, Yingfei Wang, Haoyang Wang, Li-Li Wang, Yanbing Wang, Yingchun Wang, Guangming Wang, Kaiyuan Wang, Shiqi Wang, Qi-En Wang, Song Wang, Jing-Hao Wang, Lynn Yuning Wang, Zekun Wang, Rui-Ping Wang, Yining E Wang, Yuzhou Wang, Liu Wang, Maochun Wang, Cindy Wang, Qian-Liang Wang, Duo-Ping Wang, Linlin Wang, Taishu Wang, Xiang Wang, Qirui Wang, Baoming Wang, Liting Wang, Jiapan Wang, Lingda Wang, Xietong Wang, Jia-Mei Wang, Liwei Wang, Shaozheng Wang, Q Wang, Timothy C Wang, Mengyue Wang, Xing Wang, Yahong Wang, Yuyong Wang, Yujiong Wang, Guangliang Wang, Ya-Qin Wang, Yezhou Wang, Hongjian Wang, Su-Hua Wang, Qian-fei Wang, Meng-Dan Wang, Yuchen Wang, Hongpin Wang, Pengfei Wang, Ge Wang, Meijun Wang, Yan-Ming Wang, Haichao Wang, Tzung-Dau Wang, Runci Wang, Yan-Yi Wang, Cheng-Jie Wang, Chen-Yu Wang, Cong Wang, Yaxuan Wang, Y H Wang, Yongjie Wang, Yuntai Wang, Ranjing Wang, Yiru Wang, Anxiang Wang, Q Z Wang, Shimiao Wang, Guoping Wang, Junke Wang, Xingyun Wang, Zhengyi Wang, Shi-Qi Wang, Yanfeng Wang, Danxin Wang, Chaodong Wang, Zhiqi Wang, Chunyu Wang, Lijia Wang, Chunlong Wang, Haiping Wang, Qingfa Wang, Yu-Fan Wang, Baihan Wang, Chunxue Wang, Liewei Wang, Xinyi Wang, Fu-Zhen Wang, Qing-Mei Wang, Sheng Wang, Yi-Tao Wang, Dawei Wang, Xiaoyu Wang, Ziling Wang, Zhonglin Wang, Rurong Wang, Qingchun Wang, Qiang Wang, Suiyan Wang, Xu-Hong Wang, Jie Jin Wang, Chenyao Wang, Fei-Yan Wang, Shi Wang, Zhiyong Wang, Jieda Wang, Xiaoqi Wang, Linshu Wang, Ruxuan Wang, Qian Wang, Qianxu Wang, Fangjie Wang, Zhaoxia Wang, Jeremy R Wang, Mingmei Wang, Jingkang Wang, Jen-Chun Wang, Changyuan Wang, Chenglin Wang, Meng-Ru Wang, Tianpeng Wang, Zhongfang Wang, Xuedong Wang, Zhuoying Wang, Bingyu Wang, Xuelai Wang, Weilong Wang, Mengge Wang, Qin Wang, Da-Li Wang, Xuanyi Wang, Hongjuan Wang, Zhi-Hua Wang, Hong-Wei Wang, Yulai Wang, Gongming Wang, Yongni Wang, Mengya Wang, Yadong Wang, Chenghao Wang, Hongbo Wang, Kaiming Wang, Haonan Wang, Guanyun Wang, Yilu Wang, Quanxi Wang, Weiyuan Wang, Xiujun Wang, Liang-Yan Wang, Jianshe Wang, Yingxiong Wang, Cunchuan Wang, Jing-Zhai Wang, Yuelong Wang, Yuqi Wang, Xiaorui Wang, Qianjin Wang, Huijun Wang, Xiaobo Wang, Guoqian Wang, Luhong Wang, Kaining Wang, Chaohui Wang, Yanhong Wang, J-Y Wang, Qi-Bing Wang, Xiaohu Wang, Jiayan Wang, Cui-Shan Wang, Lulu Wang, Yong-Jie Wang, Shixuan Wang, Yuanyuan Wang, Jianying Wang, Haizhen Wang, Shuiliang Wang, Qianbao Wang, Jung-Pan Wang, Rixiang Wang, A Wang, Hanbing Wang, Caiqin Wang, Peigeng Wang, Yuan Wang, Yuzhuo Wang, Yubo Wang, Xianding Wang, Qiaoqi Wang, Cuiling Wang, Ai-Ling Wang, Hailong Wang, Yihao Wang, Lan-Wan Wang, Haihe Wang, S Wang, Sha Wang, Xiaoli Wang, David Q H Wang, Jianfang Wang, Yuting Wang, Jinhuan Wang, Kaixu Wang, Hongwei Wang, Yi-Wen Wang, Yizhe Wang, Shengyu Wang, Yanmei Wang, Huimin Wang, Youjie Wang, Kunhua Wang, Chongjian Wang, Ziyun Wang, Tianhui Wang, Huiying Wang, Yue-Nan Wang, Peiyin Wang, Hongbin Wang, Hong Yi Wang, Xinjun Wang, Yian Wang, Liyi Wang, Yunce Wang, Yi-Xuan Wang, Yitao Wang, Jiali Wang, Junqin Wang, Yuebing Wang, Yiping Wang, Yunpeng Wang, Yuxing Wang, Shuqi Wang, Ziyu Wang, Hongjie Wang, Xiaoyan Wang, Lianshui Wang, Xiaolu Wang, Wenya Wang, Fan Wang, Jinhua Wang, Sidan Wang, Lixiang Wang, Y L Wang, Xue-Rui Wang, Kai-Wen Wang, Zhongyu Wang, Xiaoyang Wang, Hongyang Wang, Rencheng Wang, Yinxiong Wang, Yuanli Wang, Zhuqing Wang, Y-H Wang, Yuhui Wang, Xitian Wang, Weizhen Wang, Qi Wang, Qiyuan Wang, Changlong Wang, Yatao Wang, Tengfei Wang, Yehan Wang
articles
Min Li, Wenye Zhu, Chu Wang +4 more · 2021 · BMC pulmonary medicine · BioMed Central · added 2026-04-24
Asthma is a heterogeneous disease that can be divided into four inflammatory phenotypes: eosinophilic asthma (EA), neutrophilic asthma (NA), mixed granulocytic asthma (MGA), and paucigranulocytic asth Show more
Asthma is a heterogeneous disease that can be divided into four inflammatory phenotypes: eosinophilic asthma (EA), neutrophilic asthma (NA), mixed granulocytic asthma (MGA), and paucigranulocytic asthma (PGA). While research has mainly focused on EA and NA, the understanding of PGA is limited. In this study, we aimed to identify underlying mechanisms and hub genes of PGA. Based on the dataset from Gene Expression Omnibus(GEO), weighted gene coexpression network analysis (WGCNA), differentially expressed genes (DEGs) analysis and protein-protein interaction (PPI) network analysis were conducted to construct a gene network and to identify key gene modules and hub genes. Functional enrichment analyses were performed to investigate the biological process, pathways and immune status of PGA. The hub genes were validated in a separate dataset. Compared to non-PGA, PGA had a different gene expression pattern, in which 449 genes were differentially expressed. One gene module significantly associated with PGA was identified. Intersection between the differentially expressed genes (DEGs) and the genes from the module that were most relevant to PGA were mainly enriched in inflammation and immune response regulation. The single sample Gene Set Enrichment Analysis (ssGSEA) suggested a decreased immune infiltration and function in PGA. Finally six hub genes of PGA were identified, including ADCY2, CXCL1, FPRL1, GPR109B, GPR109A and ADCY3, which were validated in a separate dataset of GSE137268. Our study characterized distinct gene expression patterns, biological processes and immune status of PGA and identified hub genes, which may improve the understanding of underlying mechanism and provide potential therapeutic targets for PGA. Show less
📄 PDF DOI: 10.1186/s12890-021-01711-3
ADCY3
Shi Yao, Hao Wu, Jing-Miao Ding +5 more · 2021 · International journal of obesity (2005) · Nature · added 2026-04-24
Childhood obesity is one of the most common and costly nutritional problems with high heritability. The genetic mechanism of childhood obesity remains unclear. Here, we conducted a transcriptome-wide Show more
Childhood obesity is one of the most common and costly nutritional problems with high heritability. The genetic mechanism of childhood obesity remains unclear. Here, we conducted a transcriptome-wide association study (TWAS) to identify novel genes for childhood obesity. By integrating the GWAS summary of childhood body mass index (BMI), we conducted TWAS analyses with pre-computed gene expression weights in 39 obesity priority tissues. The GWAS summary statistics of childhood BMI were derived from the early growth genetics consortium with 35,668 children from 20 studies. We identified 15 candidate genes for childhood BMI after Bonferroni corrections. The most significant gene, ADCY3, was identified in 13 tissues, including adipose, brain, and blood. Interestingly, eight genes were only identified in the specific tissue, such as FAIM2 in the brain (P = 2.04 × 10 Our study identified multiple candidate genes for childhood BMI, providing novel clues for understanding the genetic mechanism of childhood obesity. Show less
no PDF DOI: 10.1038/s41366-021-00780-y
ADCY3
Yin-Hong Cao, Song-Song Xu, Min Shen +39 more · 2021 · Molecular biology and evolution · Oxford University Press · added 2026-04-24
How animals, particularly livestock, adapt to various climates and environments over short evolutionary time is of fundamental biological interest. Further, understanding the genetic mechanisms of ada Show more
How animals, particularly livestock, adapt to various climates and environments over short evolutionary time is of fundamental biological interest. Further, understanding the genetic mechanisms of adaptation in indigenous livestock populations is important for designing appropriate breeding programs to cope with the impacts of changing climate. Here, we conducted a comprehensive genomic analysis of diversity, interspecies introgression, and climate-mediated selective signatures in a global sample of sheep and their wild relatives. By examining 600K and 50K genome-wide single nucleotide polymorphism data from 3,447 samples representing 111 domestic sheep populations and 403 samples from all their seven wild relatives (argali, Asiatic mouflon, European mouflon, urial, snow sheep, bighorn, and thinhorn sheep), coupled with 88 whole-genome sequences, we detected clear signals of common introgression from wild relatives into sympatric domestic populations, thereby increasing their genomic diversities. The introgressions provided beneficial genetic variants in native populations, which were significantly associated with local climatic adaptation. We observed common introgression signals of alleles in olfactory-related genes (e.g., ADCY3 and TRPV1) and the PADI gene family including in particular PADI2, which is associated with antibacterial innate immunity. Further analyses of whole-genome sequences showed that the introgressed alleles in a specific region of PADI2 (chr2: 248,302,667-248,306,614) correlate with resistance to pneumonia. We conclude that wild introgression enhanced climatic adaptation and resistance to pneumonia in sheep. This has enabled them to adapt to varying climatic and environmental conditions after domestication. Show less
📄 PDF DOI: 10.1093/molbev/msaa236
ADCY3
Yan Gao, Ning Wu, Shuai Wang +3 more · 2021 · Breast cancer research and treatment · Springer · added 2026-04-24
HER2-positive breast cancer patients benefit from HER2-targeted therapies, among which the most commonly used is trastuzumab. However, acquired resistance typically happens within one year. The cellul Show more
HER2-positive breast cancer patients benefit from HER2-targeted therapies, among which the most commonly used is trastuzumab. However, acquired resistance typically happens within one year. The cellular heterogeneity of it is less clear. Here we generated trastuzumab-resistant cells in two HER2-positive breast cancer cell lines, SK-BR-3 and BT-474. Cells at different time points during the resistance induction were examined by exome sequencing to study changes of genomic alterations over time. Single cell-targeted sequencing was also used to identify resistance-associated concurrent mutations. We found a rapid increase of copy number variation (CNV) regions and gradual accumulation of single nucleotide variations (SNVs). On the pathway level, non-synonymous SNVs for SK-BR-3 cells were enriched in the MAPK signaling pathway, while for BT-474 cells they were enriched in mTOR and PI3K-Akt signaling pathways. However, all of the three signaling pathways were in the downstream of the HER2 kinase. Putative trastuzumab-resistance-associated SNVs included AIFM1 P548L and ERBB2 M833R in SK-BR-3 cells, and ADAMTS19 V451L, OR5M9 D230N, COL9A1 R627T, and ITGA7 H911Q in BT-474 cells. Single-cell-targeted sequencing identified several concurrent mutations. By validation, we found that concurrent mutations (AIFM1 P548L and IL1RAPL2 S546C in SK-BR-3 cells, MFSD11 L242I and ANAPC4 E16K in BT-474 cells) led to a decrease of trastuzumab sensitivity. Taken together, our study revealed a common pathway level trastuzumab-resistance mechanism for HER2-positive breast cancer cells. In addition, our identification of concurrent SNVs associated with trastuzumab-resistance may be indicative of potential targets for the treatment of trastuzumab-resistant breast cancer patients. Show less
📄 PDF DOI: 10.1007/s10549-021-06237-0
ANAPC4
Jing Yang, Xin Yu, Guirong Zhu +12 more · 2021 · Oral diseases · Blackwell Publishing · added 2026-04-24
To explore susceptibility genes and pathways for non-syndromic cleft lip with or without cleft palate (NSCL/P). Two genome-wide association studies (GWAS) datasets, including 858 NSCL/P cases and 1,24 Show more
To explore susceptibility genes and pathways for non-syndromic cleft lip with or without cleft palate (NSCL/P). Two genome-wide association studies (GWAS) datasets, including 858 NSCL/P cases and 1,248 controls, were integrated with expression quantitative trait loci (eQTL) dataset identified by Genotype-Tissue Expression (GTEx) project in whole-blood samples. The expression of the candidate genes in mouse orofacial development was inquired from FaceBase. Protein-protein interaction (PPI) network was visualized to identify protein functions. Go and KEGG pathway analyses were performed to explore the underlying risk pathways. A total of 233 eQTL single-nucleotide polymorphisms (SNPs) in 432 candidate genes were identified to be associated with the risk of NSCL/P. One hundred and eighty-three susceptible genes were expressed in mouse orofacial development according to FaceBase. PPI network analysis highlighted that these genes involved in ubiquitin-mediated proteolysis (KCTD7, ASB1, UBOX5, ANAPC4) and DNA synthesis (XRCC3, RFC3, KAT5, RHNO1) were associated with the risk of NSCL/P. GO and KEGG pathway analyses revealed that the fatty acid metabolism pathway (ACADL, HSD17B12, ACSL5, PPT1, MCAT) played an important role in the development of NSCL/P. Our results identified novel susceptibility genes and pathways associated with the development of NSCL/P. Show less
no PDF DOI: 10.1111/odi.13699
ANAPC4
Xitong Zhao, Huatao Liu, Yongjie Pan +6 more · 2021 · Frontiers in genetics · Frontiers · added 2026-04-24
Preadipocyte differentiation plays an important role in lipid deposition and affects fattening efficiency in pigs. In the present study, preadipocytes isolated from the subcutaneous adipose tissue of Show more
Preadipocyte differentiation plays an important role in lipid deposition and affects fattening efficiency in pigs. In the present study, preadipocytes isolated from the subcutaneous adipose tissue of three Landrace piglets were induced into mature adipocytes Show less
📄 PDF DOI: 10.3389/fgene.2021.753725
ANGPTL4
Qi Jiang, Ye Pan, Ping Li +6 more · 2021 · Frontiers in endocrinology · Frontiers · added 2026-04-24
This study aims to characterize the expression of ANGPTL4 in ovarian granulosa cells (GCs) and its association with polycystic ovary syndrome (PCOS). This study included 104 PCOS patients and 112 wome Show more
This study aims to characterize the expression of ANGPTL4 in ovarian granulosa cells (GCs) and its association with polycystic ovary syndrome (PCOS). This study included 104 PCOS patients and 112 women in control group undergoing The RT-qPCR results showed that ANGPTL4 expression in the control group was significantly lower than that in the PCOS group ( Our study revealed higher ANGPTL4 expression in ovarian GCs with PCOS. Its association with glucose and lipid metabolism showed that ANGPTL4 might play an important role in PCOS metabolism and pathogenesis. Show less
📄 PDF DOI: 10.3389/fendo.2021.799833
ANGPTL4
Jing Li, Xiaojie Quan, Yue Zhang +7 more · 2021 · Cells · MDPI · added 2026-04-24
Exposure to the antibacterial agent triclosan (TCS) is associated with abnormal placenta growth and fetal development during pregnancy. Peroxisome proliferator-activated receptor γ (PPARγ) is crucial Show more
Exposure to the antibacterial agent triclosan (TCS) is associated with abnormal placenta growth and fetal development during pregnancy. Peroxisome proliferator-activated receptor γ (PPARγ) is crucial in placenta development. However, the mechanism of PPARγ in placenta injury induced by TCS remains unknown. Herein, we demonstrated that PPARγ worked as a protector against TCS-induced toxicity. TCS inhibited cell viability, migration, and angiogenesis dose-dependently in HTR-8/SVneo and JEG-3 cells. Furthermore, TCS downregulated expression of PPARγ and its downstream viability, migration, angiogenesis-related genes Show less
📄 PDF DOI: 10.3390/cells11010086
ANGPTL4
Chunyan Wei, Xiaoqing Liu, Qin Wang +2 more · 2021 · International journal of endocrinology · added 2026-04-24
The 5-year overall survival rate of ovarian cancer (OC) patients is less than 40%. Hypoxia promotes the proliferation of OC cells and leads to the decline of cell immunity. It is crucial to find poten Show more
The 5-year overall survival rate of ovarian cancer (OC) patients is less than 40%. Hypoxia promotes the proliferation of OC cells and leads to the decline of cell immunity. It is crucial to find potential predictors or risk model related to OC prognosis. This study aimed at establishing the hypoxia-associated gene signature to assess tumor immune microenvironment and predicting the prognosis of OC. The gene expression data of 378 OC patients and 370 OC patients were downloaded from datasets. The hypoxia risk model was constructed to reflect the immune microenvironment in OC and predict prognosis. 8 genes (AKAP12, ALDOC, ANGPTL4, CITED2, ISG20, PPP1R15A, PRDX5, and TGFBI) were included in the hypoxic gene signature. Patients in the high hypoxia risk group showed worse survival. Hypoxia signature significantly related to clinical features and may serve as an independent prognostic factor for OC patients. 2 types of immune cells, plasmacytoid dendritic cell and regulatory T cell, showed a significant infiltration in the tissues of the high hypoxia risk group patients. Most of the immunosuppressive genes (such as ARG1, CD160, CD244, CXCL12, DNMT1, and HAVCR1) and immune checkpoints (such as CD80, CTLA4, and CD274) were upregulated in the high hypoxia risk group. Gene sets related to the high hypoxia risk group were associated with signaling pathways of cell cycle, MAPK, mTOR, PI3K-Akt, VEGF, and AMPK. The hypoxia risk model could serve as an independent prognostic indicator and reflect overall immune response intensity in the OC microenvironment. Show less
📄 PDF DOI: 10.1155/2021/4156187
ANGPTL4
Fan-Jie Liu, Liang-Yu Xie, Hua-Zhong Li +4 more · 2021 · Disease markers · added 2026-04-24
Angiopoietin-like protein 4 (ANGPTL4), encoding a glycosylated secreted protein, has been reported to be closely related to many kinds of diseases, including diabetes, tumor, and some musculoskeletal Show more
Angiopoietin-like protein 4 (ANGPTL4), encoding a glycosylated secreted protein, has been reported to be closely related to many kinds of diseases, including diabetes, tumor, and some musculoskeletal pathologies, such as rheumatoid arthritis, osteoarthritis, and osteoporosis. The aim of the current study is to investigate the role of ANGPTL4 in intervertebral disc degeneration and analyze the association of ANGPTL4 expression with Pfirrmann grades. A total of 162 nucleus pulposus tissues were collected from lumbar intervertebral disc herniation patients undergoing interforaminal endoscopic surgery. Real-time quantitative PCR and western blot were performed to determine the mRNA and protein expression of ANGPTL4 in nucleus pulposus samples. Statistical analysis was performed to analyze the association of ANGPTL4 expression with Pfirrmann grades. Based on the clinical data of 162 patients, results showed that Pfirrmann grades were significantly associated with patients' age ( The results demonstrated that ANGPTL4 expression was positively associated with the Pfirrmann grades and the severity of intervertebral disc degeneration. ANGPTL4 may be served as a candidate biomarker for intervertebral disc degeneration. Show less
📄 PDF DOI: 10.1155/2021/3532716
ANGPTL4
Liang Zhou, Guangyan Xu, Li Wang +2 more · 2021 · Disease markers · added 2026-04-24
An interaction between hypoxia and immunity has been confirmed in tumor tissue. However, there is no combined biomarker for diagnosis on this basis. Therefore, we developed a scoring formula based on Show more
An interaction between hypoxia and immunity has been confirmed in tumor tissue. However, there is no combined biomarker for diagnosis on this basis. Therefore, we developed a scoring formula based on markers of hypoxia and immunity. Firstly, the hypoxia-immune formula of lung adenocarcinoma (LUAD) was derived using LASSO-Cox regression in three cohorts from public database, and the corresponding score was calculated for each patient. The formula is as follows: combined hypoxia and immune index (CIHI) = LDHA expression × 0.2252 + GAPDH expression × 0.0727 + ANGPTL4 expression × 0.0724 + VEGFC expression × 0.1911 + DKK1 expression × 0.1355 + ADM expression × 0.0588 + BTK expression × -0.1659. Meanwhile, patients were divided into groups according to high and low CIHI, and expression profiles of hypoxia markers and immune markers were analyzed in different groups. CIHI was used to confirm that patients with high CIHI represented a state of hypoxia Show less
📄 PDF DOI: 10.1155/2021/4495489
ANGPTL4
Jung-Chien Cheng, Lanlan Fang, Yuxi Li +11 more · 2021 · Communications biology · Nature · added 2026-04-24
Insufficient invasion of trophoblast cells into the uterine decidua is associated with preeclampsia (PE). G protein-coupled estrogen receptor (GPER) is a membrane estrogen receptor involved in non-gen Show more
Insufficient invasion of trophoblast cells into the uterine decidua is associated with preeclampsia (PE). G protein-coupled estrogen receptor (GPER) is a membrane estrogen receptor involved in non-genomic estrogen signaling. GPER is expressed in human trophoblast cells and downregulated GPER levels are noted in PE. However, to date, the role of GPER in trophoblast cells remains largely unknown. Here, we applied RNA sequencing (RNA-seq) to HTR-8/SVneo human trophoblast cells in response to G1, an agonist of GPER, and identified angiopoietin-like 4 (ANGPTL4) as a target gene of GPER. Treatment of trophoblast cells with G1 or 17β-estradiol (E2) activated Yes-associated protein (YAP), the major downstream effector of the Hippo pathway, via GPER but in a mammalian STE20-like protein kinase 1 (MST1)-independent manner. Using pharmacological inhibitors as well as loss- and gain-of-function approaches, our results revealed that YAP activation was required for GPER-stimulated ANGPTL4 expression. Transwell invasion assays demonstrated that activation of GPER-induced ANGPTL4 promoted cell invasion. In addition, the expression levels of GPER, YAP, and ANGPTL4 were downregulated in the placenta of patients with PE. Our findings reveal a mechanism by which GPER exerts its stimulatory effect on human trophoblast cell invasion by upregulating YAP-mediated ANGPTL4 expression. Show less
📄 PDF DOI: 10.1038/s42003-021-02816-5
ANGPTL4
Ting Sun, Wanlin Zhan, Lijiang Wei +5 more · 2021 · Lipids in health and disease · BioMed Central · added 2026-04-24
We investigated the role of ANGPTL3 and ANGPTL4 in atherosclerosis development and determined whether plasma concentrations of ANGPTL3 and ANGPTL4 are related to the degree of coronary stenosis. A tot Show more
We investigated the role of ANGPTL3 and ANGPTL4 in atherosclerosis development and determined whether plasma concentrations of ANGPTL3 and ANGPTL4 are related to the degree of coronary stenosis. A total of 305 consecutive patients with angina who underwent diagnostic coronary angiography were enrolled in the study between August 2017 and August 2018. The levels of ANGPTL3 and ANGPTL4 were measured by using competitive ELISA kits. According to the degree of coronary artery stenosis, patients were classified into four types: coronary artery stenosis of < 10%, 10-50%, 50-75, and > 75%. The plasma ANGPTL3 level was higher (51.71 ± 52.67 vs. 24.65 ± 10.32 ng/mL, P < 0.001) and that of ANGPTL4 was lower (454.66 ± 269.05 vs. 875.49 ± 961.15 ng/mL, P < 0.001) in the coronary artery stenosis ≥ 10% group than in the < 10% group. ANGPTL3 and ANGPTL4 levels were significantly associated with the severity of coronary vascular stenosis. ROC curve analyses indicated that ANGPTL3 concentrations above 30.5 ng/mL can predict atherosclerosis with a sensitivity of 71.2% and specificity of 75.3%, and that ANGPTL4 levels below 497.5 ng/mL can predict atherosclerosis with a sensitivity of 63.9% and specificity of 74.5%. ANGPTL3 and ANGPTL4 were determined to be independent risk factors for coronary atherosclerosis with odds ratios (ORs) of 0.189 (95% CI 0.097-0.368, P < 0.001) and 3.625 (95% CI 1.873-7.016, P < 0.001), respectively. Increased ANGPTL3 or decreased ANGPTL4 shows an association with coronary atherosclerosis and, may become a predictor of coronary atherosclerosis in the future. Show less
📄 PDF DOI: 10.1186/s12944-021-01580-z
ANGPTL4
Feng Wang, Cheng Chen, Wei-Peng Chen +2 more · 2021 · BioMed research international · added 2026-04-24
Ferroptosis is a mode of regulated cell death that depends on iron and plays pivotal roles in regulating various biological processes in human cancers. However, the role of ferroptosis in gastric canc Show more
Ferroptosis is a mode of regulated cell death that depends on iron and plays pivotal roles in regulating various biological processes in human cancers. However, the role of ferroptosis in gastric cancer (GC) remains unclear. In our study, a total of 2721 differentially expressed genes (DEGs) were filtered based on The Cancer Genome Atlas (TCGA) ( Show less
📄 PDF DOI: 10.1155/2021/6014202
ANGPTL4
Wei-Lun Tsai, Chih-Yang Wang, Yu-Cheng Lee +5 more · 2021 · Biomedicines · MDPI · added 2026-04-24
The development and progression of colorectal cancer (CRC) involve changes in genetic and epigenetic levels of oncogenes and/or tumor suppressors. In spite of advances in understanding of the molecula Show more
The development and progression of colorectal cancer (CRC) involve changes in genetic and epigenetic levels of oncogenes and/or tumor suppressors. In spite of advances in understanding of the molecular mechanisms involved in CRC, the overall survival rate of CRC still remains relatively low. Thus, more research is needed to discover and investigate effective biomarkers and targets for diagnosing and treating CRC. The roles of long non-coding RNAs (lncRNAs) participating in various aspects of cell biology have been investigated and potentially contribute to tumor development. Our recent study also showed that CRNDE was among the top 20 upregulated genes in CRC clinical tissues compared to normal colorectal tissues by analyzing a Gene Expression Omnibus (GEO) dataset (GSE21815). Although CRNDE is widely reported to be associated with different types of cancer, most studies of CRNDE were limited to examining regulation of its transcription levels, and in-depth mechanistic research is lacking. In the present study, CRNDE was found to be significantly upregulated in CRC patients at an advanced TNM stage, and its high expression was correlated with poor outcomes of CRC patients. In addition, we found that knocking down CRNDE could reduce lipid accumulation through the miR-29b-3p/ANGPTL4 axis and consequently induce autophagy of CRC cells. Show less
📄 PDF DOI: 10.3390/biomedicines9101438
ANGPTL4
Lei Dai, Yang Xie, Wenjun Zhang +7 more · 2021 · Frontiers in endocrinology · Frontiers · added 2026-04-24
Diabetic cardiomyopathy (DbCM) is characterized by initial impairment of left ventricular relaxation followed by contractile dysfunction. Despite intensive research, the exact mechanism remains so far Show more
Diabetic cardiomyopathy (DbCM) is characterized by initial impairment of left ventricular relaxation followed by contractile dysfunction. Despite intensive research, the exact mechanism remains so far unsolved. We constructed weighted gene co-expression network analysis (WGCNA) to screen gene modules that were closely related with DbCM based on the GSE5606 dataset, which contained expression data of the cardiac left ventricle in a rodent model of streptozotocin (STZ)-induced DbCM. Then, the most related hub gene, angiopoietin-like 4 (ANGPTL4), was selected for functional WGCNA analysis revealed the yellow and green modules were most correlated with DbCM, and identified ANGPTL4 as one of the most significantly upregulated hub genes ( We found Show less
📄 PDF DOI: 10.3389/fendo.2021.705154
ANGPTL4
Dai Zhang, Yiche Li, Si Yang +10 more · 2021 · Cancer medicine · Wiley · added 2026-04-24
Ovarian cancer (OV) is deemed the most lethal gynecological cancer in women. The aim of this study was to construct an effective gene prognostic model for predicting overall survival (OS) in patients Show more
Ovarian cancer (OV) is deemed the most lethal gynecological cancer in women. The aim of this study was to construct an effective gene prognostic model for predicting overall survival (OS) in patients with OV. The expression profiles of glycolysis-related genes (GRGs) and clinical data of patients with OV were extracted from The Cancer Genome Atlas (TCGA) database. Univariate, multivariate, and least absolute shrinkage and selection operator Cox regression analyses were conducted, and a prognostic signature based on GRGs was constructed. The predictive ability of the signature was analyzed using training and test sets. A gene risk signature based on nine GRGs (ISG20, CITED2, PYGB, IRS2, ANGPTL4, TGFBI, LHX9, PC, and DDIT4) was identified to predict the survival outcome of patients with OV. The signature showed a good prognostic ability for OV, particularly high-grade OV, in the TCGA dataset, with areas under the curve (AUC) of 0.709 and 0.762 for 3- and 5-year survival, respectively. Similar results were found in the test sets, and the AUCs of 3-, 5-year OS were 0.714 and 0.772 in the combined test set. And our signature was an independent prognostic factor. Moreover, a nomogram combining the prediction model and clinical factors was developed. Our study established a nine-GRG risk model and nomogram to better predict OS in patients with OV. The risk model represents a promising and independent prognostic predictor for patients with OV. Moreover, our study on GRGs could offer guidance for the elucidation of underlying mechanisms in future studies. Show less
📄 PDF DOI: 10.1002/cam4.4317
ANGPTL4
Zi-Yi Wang, Jian-Yu Lin, Yang-Rong Feng +8 more · 2021 · World journal of gastroenterology · added 2026-04-24
Intestinal barrier breakdown, a frequent complication of intestinal ischemia-reperfusion (I/R) including dysfunction and the structure changes of the intestine, is characterized by a loss of tight jun Show more
Intestinal barrier breakdown, a frequent complication of intestinal ischemia-reperfusion (I/R) including dysfunction and the structure changes of the intestine, is characterized by a loss of tight junction and enhanced permeability of the intestinal barrier and increased mortality. To develop effective and novel therapeutics is important for the improvement of outcome of patients with intestinal barrier deterioration. Recombinant human angiopoietin-like protein 4 (rhANGPTL4) is reported to protect the blood-brain barrier when administered exogenously, and endogenous ANGPTL4 deficiency deteriorates radiation-induced intestinal injury. To identify whether rhANGPTL4 may protect intestinal barrier breakdown induced by I/R. Intestinal I/R injury was elicited through clamping the superior mesenteric artery for 60 min followed by 240 min reperfusion. Intestinal epithelial (Caco-2) cells and human umbilical vein endothelial cells were challenged by hypoxia/ reoxygenation to mimic I/R Indicators including fluorescein isothiocyanate-conjugated dextran (4 kilodaltons; FD-4) clearance, ratio of phosphorylated myosin light chain/total myosin light chain, myosin light chain kinase and loss of zonula occludens-1, claudin-2 and VE-cadherin were significantly increased after intestinal I/R or cell hypoxia/reoxygenation. rhANGPTL4 treatment significantly reversed these indicators, which were associated with inhibiting the inflammatory and oxidative cascade, excessive activation of cellular autophagy and apoptosis and improvement of survival rate. Similar results were observed rhANGPTL4 can function as a protective agent against intestinal injury induced by intestinal I/R and improve survival Show less
📄 PDF DOI: 10.3748/wjg.v27.i32.5404
ANGPTL4
Fang-Tao Wang, Xin-Ping Li, Mu-Su Pan +3 more · 2021 · Cancer medicine · Wiley · added 2026-04-24
Cancer-associated fibroblasts (CAFs) with different gene profiles from normal fibroblasts (NFs) have been implicated in tumor progression. Angiopoietin-like protein 4 (ANGPTL4) has been shown to regul Show more
Cancer-associated fibroblasts (CAFs) with different gene profiles from normal fibroblasts (NFs) have been implicated in tumor progression. Angiopoietin-like protein 4 (ANGPTL4) has been shown to regulate tumor angiogenesis and metastasis, and predict poor prognosis. However, the ANGPTL4 expression in CAFs, especially in gallbladder CAFs (GCAFs) and its relationship with patient prognosis is unclear. Affymetrix gene profile chip analysis in vitro was performed to detect the different gene expression profiles between GCAFs and NFs. RT-qPCR, immunohistochemistry, and western blotting were performed to investigate the different expression levels of ANGPTL4 in GCAFs/NFs in vitro and in an in vivo nude mouse model of xenograft tumors. Finally, the ANGPTL4 expression was investigated in the stroma of different lesion tissues of the human gallbladder by immunohistochemistry, especially the expression in GCAFs in vivo by co-immunofluorescence, and their prognostic significance in patients with gallbladder cancer (GBC) was assessed. ANGPTL4 was upregulated in both GCAFs in vitro and in the xenograft stroma of nude mice in vivo, and its expression was also significantly upregulated in human GBC stroma co-localized with the interstitial markers fibroblast secreted protein-1 and α-smooth muscle actin. In addition, the elevated ANGPTL4 expression in GCAFs was correlated with tumor differentiation, liver metastasis, venous invasion and Nevin staging, and GBC patients with an elevated ANGPTL4 expression in GACFs were found to have a lower survival rate. Increased ANGPTL4 expression in GCAFs correlates with poor patient prognosis, which indicates a potential therapeutic target for human GBCs. Show less
📄 PDF DOI: 10.1002/cam4.4150
ANGPTL4
Jing Yu, Ting-Ting Liu, Lei-Lei Liang +8 more · 2021 · Cancer cell international · BioMed Central · added 2026-04-24
Ovarian cancer (OC) is the most lethal gynaecological tumor. Changes in glycolysis have been proven to play an important role in OC progression. We aimed to identify a novel glycolysis-related gene si Show more
Ovarian cancer (OC) is the most lethal gynaecological tumor. Changes in glycolysis have been proven to play an important role in OC progression. We aimed to identify a novel glycolysis-related gene signature to better predict the prognosis of patients with OC. mRNA and clinical data were obtained from The Cancer Genome Atlas (TCGA), International Cancer Genome Consortium (ICGC) and Genotype Tissue Expression (GTEx) database. The "limma" R package was used to identify glycolysis-related differentially expressed genes (DEGs). Then, a multivariate Cox proportional regression model and survival analysis were used to develop a glycolysis-related gene signature. Furthermore, the TCGA training set was divided into two internal test sets for validation, while the ICGC dataset was used as an external test set. A nomogram was constructed in the training set, and the relative proportions of 22 types of tumor-infiltrating immune cells were evaluated using the "CIBERSORT" R package. The enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were determined by single-sample gene set enrichment analysis (ssGSEA) with the "GSVA" R package. Finally, the expression and function of the unreported signature genes ISG20 and SEH1L were explored using immunohistochemistry, western blotting, qRT-PCR, proliferation, migration, invasion and xenograft tumor assays. A five-gene signature comprising ANGPTL4, PYGB, ISG20, SEH1L and IRS2 was constructed. This signature could predict prognosis independent of clinical factors. A nomogram incorporating the signature and three clinical features was constructed, and the calibration plot suggested that the nomogram could accurately predict the survival rate. According to ssGSEA, the signature was associated with KEGG pathways related to axon guidance, mTOR signalling, tight junctions, etc. The proportions of tumor-infiltrating immune cells differed significantly between the high-risk group and the low-risk group. The expression levels of ISG20 and SEH1L were lower in tumor tissues than in normal tissues. Overexpression of ISG20 or SEH1L suppressed the proliferation, migration and invasion of Caov3 cells in vitro and the growth of xenograft tumors in vivo. Five glycolysis-related genes were identified and incorporated into a novel risk signature that can effectively assess the prognosis and guide the treatment of OC patients. Show less
📄 PDF DOI: 10.1186/s12935-021-02045-0
ANGPTL4
Wei Wang, Bo Wang · 2021 · International immunopharmacology · Elsevier · added 2026-04-24
This study aimed to discuss the expression of angiogenesis-related proteins in bone marrow mesenchymal stem cells (BMSCs) induced by osteoprotegerin (OGP) during osteogenic differentiation in rats, an Show more
This study aimed to discuss the expression of angiogenesis-related proteins in bone marrow mesenchymal stem cells (BMSCs) induced by osteoprotegerin (OGP) during osteogenic differentiation in rats, and to analyze the effect of fracture healing inflammatory factor TNF-ɑ on the osteogenic differentiation of BMSCs of rats. BMSCs isolated and cultured from the third generation rats were taken as the research object. According to the addition amount of OGP, BMSCs were divided into control group, OGP (10 Show less
no PDF DOI: 10.1016/j.intimp.2021.107821
ANGPTL4
Xu Zhao, Huashan Huang, Xiao Ding +3 more · 2021 · Poultry science · Elsevier · added 2026-04-24
The objective of this study was to determine the effects of angiopoietin-like protein 4 (ANGPTL4) on breast muscle lipid metabolism in broilers. In experiment 1, 36 thirty-five-day-old male Arbor Acre Show more
The objective of this study was to determine the effects of angiopoietin-like protein 4 (ANGPTL4) on breast muscle lipid metabolism in broilers. In experiment 1, 36 thirty-five-day-old male Arbor Acres broilers were randomly allocated into 6 treatment groups with 6 birds in a completely randomized design. The broilers were subjected to intravenous injection of His-SUMO-ANGPTL4 at the dose of 0 (injection of normal saline [NS]), 20, 100, 500, 2,500, or 12,500 ng/kg BW, respectively. The results showed that broilers at 30 min after His-SUMO-ANGPTL4 at the level of 12,500 ng/kg BW intravenous injection had higher (P < 0.05) concentrations of triglyceride and non-esterified fatty acid in the serum, higher (P < 0.05) adipose triglyceride lipase and carnitine palmitoyltransferase 1 mRNA expression in the breast muscle, but lower (P < 0.05) lipoprotein lipase (LPL) mRNA expression in the breast muscle. In experiment 2, 18 thirty-five-day-old male Arbor Acres broilers were randomly allocated into 3 treatment groups with 6 birds in a completely randomized design. The broilers were subjected to intravenous injection of NS, His-SUMO, or His-SUMO-ANGPTL4 (12,500 ng/kg BW) in order to rule out the effect of His-SUMO tag. It's confirmed that ANGPTL4 could increase (P < 0.05) concentrations of triglyceride and non-esterified fatty acid in the serum, enhance (P < 0.05) adipose triglyceride lipase mRNA expression in the breast muscle, and decrease (P < 0.05) LPL mRNA expression in the breast muscle. In experiment 3 and 4, co-culture experiments of chicken primary myoblasts and NS, His-SUMO, or His-SUMO-ANGPTL4 (250 pg/mL, physiological dose) were set up to monitor the cytotoxicity of ANGPTL4 and the changes of lipid metabolism-related genes expression. It was found that cell viability was not affected but LPL mRNA expression in chicken primary myoblasts was highly reduced (P < 0.05) by ANGPTL4. In conclusion, ANGPTL4 could promote lipodieresis and inhibit LPL in the breast muscle of broilers. Show less
📄 PDF DOI: 10.1016/j.psj.2021.101159
ANGPTL4
Jing Wang, Xiaoqin Ma, Qi Zhang +4 more · 2021 · Frontiers in cell and developmental biology · Frontiers · added 2026-04-24
Congenital heart defect (CHD) is a rare and complicated disease with a high mortality rate. Its etiology remains unclear and includes many aspects. DNA methylation has been indicated to be involved in Show more
Congenital heart defect (CHD) is a rare and complicated disease with a high mortality rate. Its etiology remains unclear and includes many aspects. DNA methylation has been indicated to be involved in heart development in the early stage of life, and aberrant methylation level was related to CHDs. This study provides the first evidence of the cross talk of SNP variants and DNA methylation in clarifying CHD underlying genomic cause. We gathered whole exome sequencing (WES) data for Group 1 consisting of patients with PA ( Show less
📄 PDF DOI: 10.3389/fcell.2021.665514
ANGPTL4
Yi-Yi Wang, Hua Duan, Sha Wang +3 more · 2021 · Reproductive biology and endocrinology : RB&E · BioMed Central · added 2026-04-24
Adenomyosis (ADS) is an estrogen-dependent gynecological disease with unspecified etiopathogenesis. Local hyperestrogenism may serve a key role in contributing to the origin of ADS. Talin1 is mostly i Show more
Adenomyosis (ADS) is an estrogen-dependent gynecological disease with unspecified etiopathogenesis. Local hyperestrogenism may serve a key role in contributing to the origin of ADS. Talin1 is mostly identified to be overexpressed and involved in the progression of numerous human carcinomas through mediating cell proliferation, adhesion and motility. Whether Talin1 exerts an oncogenic role in the pathogenesis of ADS and puts an extra impact on the efficacy of estrogen, no relevant data are available yet. Here we demonstrated that the adenomyotic eutopic and ectopic endometrial stromal cells (ADS_Eu_ESC and ADS_Ec_ESC) treated with β-estradiol (β-E Show less
📄 PDF DOI: 10.1186/s12958-021-00756-7
ANGPTL4
Jun Hu, Lian Liu, Xianghu Zeng +8 more · 2021 · Shock (Augusta, Ga.) · added 2026-04-24
Angiopoietin-like 4 (ANGPTL4) is a secreted glycoprotein that plays an important role in endothelial injury and the inflammatory response. Experimental models have implicated ANGPTL4 in acute respirat Show more
Angiopoietin-like 4 (ANGPTL4) is a secreted glycoprotein that plays an important role in endothelial injury and the inflammatory response. Experimental models have implicated ANGPTL4 in acute respiratory distress syndrome (ARDS), but its impact on the progression of ARDS is unclear. Paired bronchoalveolar lavage fluid (BALF) and serum samples were obtained from patients with ARDS (n = 56) within 24 h of diagnosis and from control subjects (n = 32). ANGPTL4, angiopoietin-2, interleukin (IL)-6, and TNF-α levels were measured by magnetic Luminex assay. BALF albumin (BA) and serum albumin (SA) were evaluated by enzyme-linked immunosorbent assay. BALF and serum ANGPTL4 concentrations were higher in patients with ARDS than in controls and were even higher in non-survivors than in survivors. The serum ANGPTL4 level was higher in indirect (extrapulmonary) ARDS than in direct (pulmonary) ARDS. Furthermore, BALF and serum ANGPTL4 levels correlated well with angiopoietin-2, IL-6, and TNF-α levels in BALF and serum. BALF ANGPTL4 was positively correlated with the BA/SA ratio (an indicator of pulmonary vascular permeability), and serum ANGPTL4 was associated with the severity of multiple organ dysfunction syndrome based on SOFA and APACHE II scores. Moreover, serum ANGPTL4 was better able to predict 28-day ARDS-related mortality (AUC 0.746, P < 0.01) than the APACHE II score or PaO2/FiO2 ratio. Serum ANGPTL4 was identified as an independent risk factor for mortality in a univariate Cox regression model (P < 0.001). ANGPTL4 levels were elevated in patients with ARDS and significantly correlated with disease severity and mortality. ANGPTL4 may be a novel prognostic biomarker in ARDS. Show less
no PDF DOI: 10.1097/SHK.0000000000001734
ANGPTL4
Hao-Hua Wang, Wan-Ying Luo, Min Lin +3 more · 2021 · Physiological research · added 2026-04-24
Asprosin, coiled-coil domain-containing 80(CCDC80) and angiopoietin-like4(ANGPTL4) are newly discovered adipocytokine that affects glucose tolerance, insulin resistance and cardiovascular diseases. Th Show more
Asprosin, coiled-coil domain-containing 80(CCDC80) and angiopoietin-like4(ANGPTL4) are newly discovered adipocytokine that affects glucose tolerance, insulin resistance and cardiovascular diseases. The goal of this study was to investigate if a relationship exists among asprosin, CCDC80 and ANGPTL4 and inflammatory bowel disease (IBD). Fifty subjects with newly diagnosed IBD and fifty healthy individuals were enrolled. Patients were treated with standard therapies for 3 months. Plasma asprosin, CCDC80 and ANGPTL4 levels were measured with enzyme-linked immunosorbent assay. High resolution ultrasound was used to measure brachial artery diameter at rest, after reactive hyperemia (flow-mediated dilation, FMD) and after sublingual glyceryltrinitrate.Compare with healthy individuals, plasma CCDC80,erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) levels and homeostasis modelassessment of insulin resistance (HOMA-IR) were significantly higher (p < 0.05, respectively), whereas plasma asprosin,ANGPTL4 levels and FMD were significantly lower inboth UC and CD patients(p <0.05). Plasma CCDC80 levels were significantly higher in patients with CD (p<0.05), while plasma asprosin and ANGPTL4 levels were lower (p<0.05) as compared with those in patients with UC. Standard therapies increased plasma asprosin, ANGPTL4 levels and FMD in both UC and CD (p<0.05),UC and CD patientswhile decreased plasma CCDC80, ESR, CRP levels and HOMA-IR (p<0.05). The changes in HOMA-IR and FMD were correlated with the changes in plasma asprosin, CCDC80 and ANGPTL4 levels over the study period (p<0.05). Plasma asprosin, CCDC80 and ANGPTL4 levels may be applied as a significant marker for early stage of insulin resistance and atherosclerosis in IBD, especially of CD. Show less
no PDF DOI: 10.33549/physiolres.934547
ANGPTL4
Xiaowei Zheng, Suwen Shen, Aili Wang +11 more · 2021 · Annals of clinical and translational neurology · Wiley · added 2026-04-24
Angiopoietin-like protein 4 (ANGPTL-4) had been reported to be associated with the risk of ischemic stroke, but its prognostic value remained unclear. The aim of this study was to investigate the asso Show more
Angiopoietin-like protein 4 (ANGPTL-4) had been reported to be associated with the risk of ischemic stroke, but its prognostic value remained unclear. The aim of this study was to investigate the association between plasma ANGPTL-4 concentrations and prognosis of ischemic stroke. Baseline plasma ANGPTL-4 concentrations were measured in 3379 acute ischemic stroke patients. The primary outcome was a combination of death or major disability (modified Rankin Scale score, ≥3) at 3 months after ischemic stroke. At 3 months after ischemic stroke, 850 (26.16%) participants experienced major disability or died (750 major disabilities and 100 deaths). After adjusting for important covariates, odds ratios for the highest tertile of plasma ANGPTL-4 concentrations were 1.59 (1.22-2.06) for primary outcome, 1.53 (1.18-1.97) for major disability, and 2.03 (1.03-4.00) for death when compared with the lowest tertile of plasma ANGPTL-4 concentrations. For 1-SD increase in log-ANGPTL-4 concentrations (0.44 ng/mL), the adjusted odds ratios were 1.24 (1.11-1.38), 1.14 (1.03-1.27), and 1.72 (1.32-2.23), respectively. Adding ANGPTL-4 to a model containing conventional risk factors improved risk prediction for composite outcome of death and major disability. Higher plasma ANGPTL-4 concentration was associated with poor prognosis in acute ischemic stroke patients, suggesting that ANGPTL-4 might be a prognostic marker for ischemic stroke. Show less
📄 PDF DOI: 10.1002/acn3.51319
ANGPTL4
Yuxin Zhang, Shenji Lu, Shuai Fan +4 more · 2021 · Aging · Impact Journals · added 2026-04-24
Joint capsule fibrosis caused by excessive inflammation leading to post-traumatic joint contracture (PTJC). Fibroblasts trigger inflammation under the challenge of various proinflammatory cytokines. M Show more
Joint capsule fibrosis caused by excessive inflammation leading to post-traumatic joint contracture (PTJC). Fibroblasts trigger inflammation under the challenge of various proinflammatory cytokines. Macrophage migration inhibitory factor (MIF) is a prominent proinflammatory cytokine involved in inflammation- and fibrosis-associated pathophysiology, we investigated the role of MIF in PTJC. Using rat PTJC model and fibroblast inflammation model, we detected MIF expression in posterior joint capsule. Primary joint capsule fibroblasts (JFs) were used to investigate the effects of MIF on cell proliferation, migration and proinflammatory cytokines production. The mechanism of JF-mediated events was evaluated by qRT-PCR, western blot and immunoprecipitation. We screened the mRNA expression profile to identify gene candidates that mediate the effect of MIF on JFs. MIF increased in posterior joint capsule following PTJC and co-localized with fibroblasts. Injection of MIF inhibitor significantly suppressed joint capsule inflammation and fibrosis. MIF/CD74 axis elicited JF inflammation and may provide new therapeutic targets for joint capsule fibrosis in PTJC. Show less
📄 PDF DOI: 10.18632/aging.202505
ANGPTL4
Zhoujie Tong, Jie Peng, Hongtao Lan +7 more · 2021 · Journal of translational medicine · BioMed Central · added 2026-04-24
The prevalence of metabolic syndrome (Mets) is closely related to an increased incidence of cardiovascular events. Angiopoietin-like protein 4 (ANGPTL4) is contributory to the regulation of lipid meta Show more
The prevalence of metabolic syndrome (Mets) is closely related to an increased incidence of cardiovascular events. Angiopoietin-like protein 4 (ANGPTL4) is contributory to the regulation of lipid metabolism, herein, may provide a target for gene-aimed therapy of Mets. This observational case control study was designed to elucidate the relationship between ANGPTL4 gene single nucleotide polymorphism (SNP) rs1044250 and the onset of Mets, and to explore the interaction between SNP rs1044250 and weight management on Mets. We have recruited 1018 Mets cases and 1029 controls in this study. The SNP rs1044250 was genotyped with blood samples, base-line information and Mets-related indicators were collected. A 5-year follow-up survey was carried out to track the lifestyle interventions and changes in Mets-related indicators. ANGPTL4 gene SNP rs1044250 is an independent risk factor for increased waist circumference (OR 1.618, 95% CI [1.119-2.340]; p = 0.011), elevated blood pressure (OR 1.323, 95% CI [1.002-1.747]; p = 0.048), and Mets (OR 1.875, 95% CI [1.363-2.580]; p < 0.001). The follow-up survey shows that rs1044250 CC genotype patients with weight gain have an increased number of Mets components (M [Q1, Q3]: CC 1 (0, 1), CT + TT 0 [- 1, 1]; p = 0.021); The interaction between SNP rs1044250 and weight management is a risk factor for increased systolic blood pressure (β = 0.075, p < 0.001) and increased diastolic blood pressure (β = 0.097, p < 0.001), the synergistic effect of weight management and SNP rs1044250 is negative (S < 1). ANGPTL4 gene SNP rs1044250 is an independent risk factor for increased waist circumference and elevated blood pressure, therefore, for Mets. However, patients with wild type SNP 1044250 are more likely to have Mets when the body weight is increased, mainly due to elevated blood pressure. Show less
📄 PDF DOI: 10.1186/s12967-021-02739-z
ANGPTL4
Qin Wang, Clare Oliver-Williams, Olli T Raitakari +11 more · 2021 · European heart journal · Oxford University Press · added 2026-04-24
Angiopoietin-like protein 3 (ANGPTL3) and 4 (ANGPTL4) inhibit lipoprotein lipase (LPL) and represent emerging drug targets to lower circulating triglycerides and reduce cardiovascular risk. To investi Show more
Angiopoietin-like protein 3 (ANGPTL3) and 4 (ANGPTL4) inhibit lipoprotein lipase (LPL) and represent emerging drug targets to lower circulating triglycerides and reduce cardiovascular risk. To investigate the molecular effects of genetic mimicry of ANGPTL3 and ANGPTL4 inhibition and compare them to the effects of genetic mimicry of LPL enhancement. Associations of genetic variants in ANGPTL3 (rs11207977-T), ANGPTL4 (rs116843064-A), and LPL (rs115849089-A) with an extensive serum lipid and metabolite profile (208 measures) were characterized in six cohorts of up to 61 240 participants. Genetic associations with anthropometric measures, glucose-insulin metabolism, blood pressure, markers of kidney function, and cardiometabolic endpoints via genome-wide summary data were also explored. ANGPTL4 rs116843064-A and LPL rs115849089-A displayed a strikingly similar pattern of associations across the lipoprotein and lipid measures. However, the corresponding associations with ANGPTL3 rs11207977-T differed, including those for low-density lipoprotein and high-density lipoprotein particle concentrations and compositions. All three genotypes associated with lower concentrations of an inflammatory biomarker glycoprotein acetyls and genetic mimicry of ANGPTL3 inhibition and LPL enhancement were also associated with lower C-reactive protein. Genetic mimicry of ANGPTL4 inhibition and LPL enhancement were associated with a lower waist-to-hip ratio, improved insulin-glucose metabolism, and lower risk of coronary heart disease and type 2 diabetes, whilst genetic mimicry of ANGPTL3 was associated with improved kidney function. Genetic mimicry of ANGPTL4 inhibition and LPL enhancement have very similar systemic metabolic effects, whereas genetic mimicry of ANGPTL3 inhibition showed differing metabolic effects, suggesting potential involvement of pathways independent of LPL. Genetic mimicry of ANGPTL4 inhibition and LPL enhancement were associated with a lower risk of coronary heart disease and type 2 diabetes. These findings reinforce evidence that enhancing LPL activity (either directly or via upstream effects) through pharmacological approaches is likely to yield benefits to human health. Show less
📄 PDF DOI: 10.1093/eurheartj/ehaa972
ANGPTL4